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ABSTRACT 
 
West Virginia University, School of Pharmacy 
Doctoral Dissertation 
 
Caroline Dong 
 
 
Diesel exhaust particles (DEP) are the major constituent of ambient particulate matter in 
urban environments and occupational settings. Exposure to DEP in combination with an 
allergen has been demonstrated to enhance allergen-related airway inflammation, 
immunoglobulin (Ig) E production, and airway responsiveness (AR) in human and in 
animal models. However, the mechanisms behind these effects of DEP are not yet fully 
understood. In this study, we compared the effects of short-term DEP exposure on 
ovalbumin (OVA)-mediated airway responses under two exposure protocols using an 
OVA-allergic rat model. Male Brown Norway rats were sensitized to aerosolized OVA 
(40.5 ± 6.3 mg/m3) on days 1, 8, and 15, and challenged with OVA on day 29. The rats 
were exposed to DEP (20 mg/m3) for 4 h/day for 5 consecutive days either before 
sensitization (protocol A) or before OVA challenge on days 24-28 (protocol B). Control 
animals received filtered air and aerosolized saline instead of DEP and OVA, 
respectively. The results showed that DEP exposure 1) elicited an adjuvant effect on 
OVA-specific IgE and IgG production in serum under both protocols; 2) significantly 
reduced OVA-induced airway inflammation and lung injury in protocol A, but increased 
these markers in protocol B; 3) markedly lowered OVA-induced production of nitric 
oxide, reactive oxygen species, and interleukin (IL)-10 and IL-12 by alveolar 
macrophages (AM) in protocol A, but increased these parameters in protocol B; 4) 
 significantly lowered the numbers of T cells and their CD4+ and CD8+ subsets in lung-
draining lymph nodes in protocol A, but increased these cell counts in protocol B;  5) 
reduced intracellular glutathione in AM and lymphocytes in both protocols; and 6) 
enhanced AR of the OVA-sensitized rats to methacholine challenge in protocol B. These 
results suggest that the effects of DEP on the immune system, including aggravation or 
exacerbation of asthma, may be greatly influenced by allergic immune status and time of 
antigen exposure. 
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1. Introduction 
 
      Asthma is an airway inflammatory disease characterized by a variable degree of 
airflow obstruction, bronchial hyperresponsiveness, and airway inflammation. The most 
prevalent form of asthma is allergic asthma. Elevation of allergen-specific 
immunoglobulin (Ig)E is one of the hallmarks of allergic diseases. IgG, on the other 
hand, has been reported to be related to late-phase asthmatic reactions and mast cell 
activation (Durham et al., 1984). An increase in activated CD4+ T helper 2 (Th2) cells in 
asthmatic airways after allergen challenge has been recognized for many years (Azzawi 
et al., 1990; Robinson et al., 1993), reinforcing an immunological basis for this disease. 
An allergic immune response to an allergen is characterized by the production of 
interleukin (IL)-4, IL-5, and IL-13 by the Th2 subset of allergen-specific CD4+ T 
lymphocytes (Ricci et al., 1994; Foster et al., 1997).  IL-4 is the cytokine required for IgE 
production, while IL-5 plays a unique role in eosinophil development and activation. In 
addition, induction of inducible nitric oxide synthase (iNOS) is also closely associated 
with allergic asthma (Trifilieff et al., 2000; Iijima et al., 2001). Allergen-induced nitric 
oxide (NO) down-regulates Th1 cytokines but up-regulates Th2 cytokine production 
(Trifilieff et al., 2000), and there were close relationships among IL-5, NO, and 
eosinophils in ovalbumin (OVA)-challenged mice, where the rise in eosinophils was 
accompanied by an increase in iNOS expression and protein nitration on epithelial 
surface and peribronchial inflammatory cells (Iijima et al., 2001).  
 
      There has been a dramatic increase in the incidence of asthma in many developed 
countries during the last decades. Although the causes for this increase are not well 
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known, a considerable amount of epidemiological evidence suggests that certain 
components of air pollution such as ozone, oxides of nitrogen and particulate matter as 
well as a variety of allergens may play important roles (Koren, 1995; Graham, 2004). 
Fine particles with widely different composition, such as carbon black (CB), titanium 
dioxide (TiO2), polystyrene, polytetrafluoroethylene, residual oil fly ash (ROFA), house 
dust, and urban ambient particles, have been reported to exhibit adjuvant effects on the 
production of IgE in response to concurrently administered allergens (Ormstad et al., 
1998; Lambert et al., 1999; van Zijverden and Granum, 2000; Hamada et al., 2000; 
Granum et al., 2001; Dybing et al., 2004). An important advance in this area is the 
discovery that diesel exhaust particles (DEP), a major component of environmental 
particulate pollutants in most industrialized urban areas, are implicated in the 
development of asthma and aggravation of pre-existing asthma (Lovik et al., 1997; 
Takano et al., 1997; Diaz-Sanchez et al., 1994, 1997). DEP, which consist of fine 
particulate and about 30% by weight organic materials adsorbed onto the carbonaceous 
core, have been shown to exert adjuvant effects on the response of humans and mice to 
inhaled or instilled allergens including increased allergen-specific IgE production, 
skewing of the immune response to Th2 cytokine production, increased eosinophils in the 
bronchoalveolar lavage (BAL) fluid, and increased airway hyperreactivity (Diaz-Sanchez 
et al., 1997, 1999;  Miyabara et al., 1998; Ohta et al., 1999).  
 
      The underlying mechanisms by which DEP exert the adjuvant effects are not yet fully 
understood. Most of the studies have been focused on the role of reactive oxygen species 
(ROS) produced on exposure to DEP and the subsequent generation of oxidative stress 
within the exposed cells. At high concentrations, ROS is responsible for protein 
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oxidation, lipid peroxidation, and DNA damage leading cellular damage in target cells 
such as macrophages and epithelial cells (Nel et al., 1998; Martin et al., 1997, Becker et 
al., 1996). At low oxidative stress levels, as defined by no or minimal changes in the 
cellular reduced glutathione (GSH)/glutathione disulfide (GSSG) ratios, the cells mount 
antioxidant and cytoprotective responses, e.g., heme-oxygenase 1 (HO-1) and superoxide 
dismutase expression (Li et al., 2001). Glutathione is a tripeptide that is found in all 
mammalian tissues and is highly concentrated in the liver. Glutathione exists in the 
reduced GSH and oxidized GSSG forms (DeLeve and Kaplowitz, 1990). GSH is the 
predominant form, existing in millimolar concentrations in most cells whereas the GSSG 
content is less than 1% of GSH (Akerboom et al., 1982). GSH has several vital functions 
including detoxifying eletrophiles, scavenging free radicals, maintaining the essential 
thiol status of proteins by preventing oxidation of -SH groups, providing a pool for 
cysteine, and modulating critical cellular processes such as DNA synthesis and immune 
function (Diaz-Sanchez et al., 1997) 
 
      Studies have shown that DEP may augment both IL-4 and IL-5- dependent allergic 
responses (Diaz-Sanchez et al., 1997; Al-Humadi et al., 2002b; Takano et al., 1997), but 
the mechanism remains unclear.  Evidence indicated that alveolar macrophages (AM), 
which are central to the inflammatory process, may play a role in the modulation of T 
cell-mediated immunity in an intracellular GSH level-dependent manner. The AM with 
high GSH content have shown to transform the naïve Th0 cells to Th1 cells, whereas AM 
with low GSH content may transform the naïve Th0 cells to Th2 cells when cultured with 
OVA-specific TCR-transgenic mouse spleen cells ( Murata et al., 2002). The 
macrophage-mediated Th1/Th2 balance is of significance, since OVA exposure resulted 
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in a dose-dependent depletion of GSH in AM that is related to increased antigen-specific 
IgE and IgG production in rats (Al-Humadi et al., 2002a). Studies have shown that 
pulmonary type II cells may also play a role in modulating T cell activity and promoting 
eosinophile-dependent airway inflammation through the secretion of IL-8 and 
granulocyte-macrophage colony-stimulating factor (GM-CSF). Evidence showed that the 
release of IL-8 and GM-CSF by human bronchial epithelial cells was induced by 
recombinant IgE-dependent histamine-releasing factor (HRF-p23), an eosinophile 
chemoattractant that is inducible by hydrogen peroxide and is found in increasing levels 
in BAL fluid of asthmatic patients (Yoneda et al., 2004).  
 
      The adjuvant effect of DEP on allergen-induced airway inflammation has been 
demonstrated primarily in various mice models (Ichinose et al., 1997, 2002; Miyabara et 
al., 1998; Takano et al., 1997, 1998). Several studies have pointed out that strain 
differences in the modulation of allergic airway inflammation and antigen-specific IgE 
and/or IgG response by DEP existed, and apparently contradictory effects of DEP were 
observed among different mouse models (Ichinose et al., 1997; 2002). Steerenberg and 
colleagues (1999, 2003) also reported the use of Brown Norway (BN) rats in elucidating 
the adjuvant effect of DEP on timothy grass pollen allergy after intranasal or intratracheal 
instillation of DEP in combination with the pollen allergen. In addition, an allergic 
asthma model of BN rats has been also established in our laboratory by sensitizing the 
animals with aerosolized OVA once a week over a month-long period that produced 
significant levels of OVA-specific IgE and IgG (Al-Humadi et al., 2002c). Exposure of 
rats to DEP (5 mg/kg) through intratracheal instillation prior to the OVA-sensitization 
enhanced production of antigen-specific antibodies at the end of allergen sensitization, 
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and this enhancement correlated with an increase in IL-4 mRNA expression in lung 
tissue. Up to the present, the adjuvant effect of DEP was demonstrated mainly from 
studies where DEP were administered in combination with an allergen during the 
sensitization process, or already-sensitized human/animal models were employed. In 
practical settings, however, subjects may be sensitized or non-sensitized to allergen(s), 
and may encounter DEP and allergen exposure at the same or different times. Different 
exposure protocols for the timing of DEP and allergen exposures therefore should be 
pursued in order to gain insight into the complex effects of DEP on the pulmonary 
immune system.  One of the important concerns raised is whether DEP, when given 
separately from an allergen, can have the adjuvant effect, i.e., augmentation of specific 
IgE or IgG response to an allergen encountered before or after DEP exposure.   
 
      Another important question regarding the involvement of DEP in allergic asthma is 
whether DEP may contribute to the chronic airway inflammation that has been 
recognized as an essential feature of the disease. A number of studies pointed out that 
fine and ultrafine particles, such as DEP, CB, ROFA, and metal particles, have the 
potential to trigger inflammatory mechanisms by modulating intracellular calcium 
concentrations, activation of transcription factors, and production of inflammatory 
cytokines through an oxidant-mediated mechanism (Sagai et al., 1996; Dick et al., 2003; 
Brown et al., 2004). These particles have also been shown to aggravate the antigen-
induced inflammation when given together with an antigen (Lovik et al., 1997; Takano et 
al., 1997; Ichinose et al., 2002). DEP are carbon-based particles containing approximately 
30% by weight various organic compounds, including PAHs, nitroaromatic compounds, 
quinones, aldehydes, and heterocyclic compounds, adsorbed onto the carbonaceous core 
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(Schuetzle, 1983; Draper, 1986). Due to the complexity of their chemical properties, DEP 
may be different from the other particles in their modulating effect on inflammatory 
response and pulmonary immunity. Indeed, a study by Melgert et al. (2004) showed that 
short term exposure of mice to cigarette smoking, a complex mixture containing fine 
carbonaceous particles and various organic compounds, inhibited OVA-induced airway 
inflammatory responses. Studies from our laboratory have previously shown that DEP or 
their organic extracts, but not the carbonaceous core, CB or silica, suppress the 
production of lipopolysaccharide (LPS)-stimulated pro-inflammatory cytokines tumor 
necrosis factor (TNF)-α and IL-12, but increase the production of anti-inflammatory IL-
10 by rat AM (Yang et al., 1999; Yin et al., 2004a, b). Previous results have shown that 
DEP aggravate OVA-induced airway inflammation when given together with the antigen 
(Takano et al., 1997, 1998; Miyabara et al., 1998; Ichinose et al., 2002). However, short-
term exposure to DEP prior to sensitization may exert an anti-inflammatory effect which 
potentially attenuates the allergen-induced airway inflammation.  
 
      The objectives of this study were to develop rat models in which animals were 
exposed to DEP before or after sensitization, and use these models to examine the effects 
of short-term DEP exposure on allergen-induced IgE and IgG production and allergic 
airway inflammation. We hypothesize that DEP exposure prior to OVA sensitization 
(protocol A) augments the sensitization process but inhibits airway inflammation though 
AM orchestrated anti-inflammatory effect, while DEP exposure after the sensitization 
(protocol B) augments allergic responses and airway hyperreactivity through, in part, by 
activation of epithelial type II cells. To investigate the underlying mechanism of these 
effects, we measured alterations in intracellular GSH levels, production of NO and 
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cytokines by AM and lymphocytes from lung-draining lymph nodes (LDLN), expression 
of iNOS in lung tissue, and alterations of CD4+ and CD8+ T cell subsets in LDLN.  
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2. Literature Review 
 
2.1 Introduction 
 
      The health effects of diesel exhaust (DE) have received increasing attention over the 
past decades. Since early 1980’s, considerable epidemiological evidence has accumulated 
to indicate that DE may exert significant adverse effects on humans. Exposure to DE may 
induce a variety of conditions including increased morbidity and mortality of lung cancer, 
allergic asthma, chronic obstructive pulmonary disease (COPD), and cardiovascular 
disorders. Experimental studies, both in vivo and in vitro, have been performed in order 
to understand the relevance of associations found in the epidemiological studies and the 
molecular and cellular mechanisms of actions. For the risk assessment of DE exposure, 
researches on the potential biomarkers of exposure, effects, and susceptibility have been 
also conducted. The aim of this review is to provide a summary of the current state of 
knowledge regarding environmental and occupational exposures to DE, epidemiological 
and experimental evidence for the adverse effects of DE exposure on human health, 
biomarkers for risk assessment, and the mechanisms by which DE exposure exerts its 
adverse health effects on humans.  
 
2.2 DE Exposures  
 
      Air pollution caused by motor vehicle exhaust has been a significant environmental 
and occupational health concern and the focus of many studies for the last decades. 
Among the motor vehicle generated air pollutants, DE, emitted by heavy-duty diesel 
engines, is a major health concern. The heavy-duty diesel engines, which are being 
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increasingly utilized for their high fuel efficiency and low levels of carbon dioxide 
emission, produce 30-100 times more particulate matter (PM) than the gasoline engines, 
making diesel exhaust particles (DEP) one of the major components of airborne PM in 
most urban and industrialized areas (Ma and Ma, 2002). DEP are carbon-based particles 
containing over several hundred different organic and inorganic components, including 
polycyclic aromatic hydrocarbons (PAHs), quinones, aldehydes, nitroaromatic and 
heterocyclic compounds, and traces of heavy metals such as iron, copper, chromium, and 
nickel, adsorbed onto the carbonaceous core (Schuetzle, 1983; Vouk et al., 1983). With a 
mass median diameter of approximately 0.2 µm and over 80% of particles being in the 
size range around 0.1 µm, DEP can remain airborne for long periods of time and deposit 
in great numbers deeply in the lungs (Sydbom et al., 2001). Although data are not 
available on long-term retention of DEP in human lungs, it has been estimated from 
animal studies that about one-fourth of the particles mass inhaled by people is deposited 
in the deeper pulmonary regions, and some of which is retained with a half-life of several 
hundred days or more (McClellan, 1987). In addition to DEP, DE contains a complex 
mixture of toxic gases such as nitrogen oxides (NOx), sulphur dioxide (SO2), carbon 
monoxide (CO), hydrocarbons, and formaldehyde (Scheepers and Bos, 1992). 
 
      Ambient concentrations of DEP vary markedly from different areas. While the 
ambient concentrations of DEP nationwide are relatively low, levels of DEP in certain 
urban areas can be considerable higher. In the Los Angeles Basin, for example, one 
estimate has placed the rate of DEP intake by humans at 0.3 mg every 1-3 days (Diaz-
Sanchez, 1997). According to a report prepared by EPA (U.S. EPA, 2002), the seasonal 
and annual average DEP concentrations in nonurban areas before 1990 ranged from 2-5 
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µg/m3. DEP concentrations for urban areas in the same timeframe ranged from 4.4-13 
µg/m3, with concentrations on individual days ranging up to 22 µg/m3. Ambient 
measurements taken in 1990 or later suggest that seasonal or annual average DEP levels 
ranged from 0.2-2.6 µg/m3, with maximum reported values ranging up to 3.4 µg/m3 in 
suburban/nonurban locations. DEP concentrations in urban areas measured in the same 
timeframe ranged from 1.7-3.6 µg/m3, with maximum concentrations up to 7.3 µg/m3. 
The highest DEP concentrations reported were those in the vicinity of a bus stop in 
midtown Manhattan, which ranged from 13.2-46.7 µg/m3. Information regarding DEP in 
occupational settings suggests a considerably higher exposure, raising an important 
health concern for exposure of truckers, railroad and construction workers, engine 
mechanics, and especially, underground miners. A report from the Department of Labor 
showed that the worst-case mean exposures to DEP in underground metal and nonmetal 
mines are about 2000 µg/m3, with maximum measurements as high as 3650 µg/m3 (U.S. 
Department of Labor, Mine Safety, and Health Administration, 1998). As reported by 
EPA (U.S. EPA, 2002), DEP exposure ranges up to approximately 1,280 µg/m3 for 
miners, with lower exposure measured for railroad workers (39-191 µg/m3), firefighters 
(4-748 µg/m3), public transit personnel who work with diesel equipment (7-98 µg/m3), 
mechanics and dockworkers (5-65 µg/m3), truck drivers (2-7 µg/m3), and bus drivers (1-3 
µg/m3). The estimated 70-year lifetime exposures equivalent to those for the occupational 
groups discussed above range from 0.4-2 µg/m3) on the low end to 2-269 µg/m3) on the 
high end (U.S. EPA, 2002).  
 
2.3 Health Effects of DEP: Epidemiological Studies 
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General Pulmonary Symptoms and Lung Function  
 
     Epidemiologic evidences showed that both chronic exposure to lower concentrations 
of DE and acute exposure to high level of DE are associated with some respiratory 
symptoms. Brunekreef et al. (1997) studied children in six areas located near major 
motorways and assessed their exposure to traffic-related air pollution using separate 
traffic counts for automobiles and trucks in the Netherlands. The results showed that 
children living on busy streets were more likely to develop chronic respiratory symptoms 
than those living on streets with less traffic, with the association becoming stronger in 
children living closest (< 300 m) to the motorways. Lung function was associated with 
truck traffic density but had a lesser association with automobile traffic density. The lung 
function was also associated with the concentration of black smoke measured inside the 
schools. These results indicated that exposure to traffic-related DE may lead to reduced 
lung function in children living near major motorways.  
 
      Occupational DE exposure occurs within working environments and usually at 
relatively high concentrations, making it possible for researchers to examine DE-
associated health effects. The results are mixed. In a study of coal miners exposed or 
unexposed to DE, Reger et al. (1982) showed that persistent cough and phlegm were 
significantly higher in DE exposed workers, but the opposite was found for dyspnea. 
Compared with nondiesel-exposed workers, DE-exposed workers had significant 
decrease in forced vital capacity (FVC), forced expiratory volume in 1 sec (FEV1), and 
forced expiratory flow (FEF) rates. Yet, in a study of diesel bus garage workers, Gamble 
et al. (1987a) showed that diesel bus garage workers had elevated prevalence of cough, 
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phlegm, and wheezing compared to "blue-collar" workers, but there was no association 
with tenure. When NO2 and respirable particles were determined with personal samplers 
and used as a surrogate measure of DE, both NO2 and respirable particle exposures were 
associated with increased postwork shift symptoms of cough, difficult or labored 
breathing, chest tightness, and wheeze but not with lung function (Gamble et al., 1987b). 
The same research group also studied the effects of DE exposure on salt miners (Gamble 
and Jones, 1983a, 1983b). There was a nonsignificant increased trend for cough and 
dyspnea and a significant trend for phlegm by years of tenure in DE-exposed jobs, but no 
association with lung function (Gamble and Jones, 1983a; Gamble et al., 1983b). Other 
studies examining the health effects of DE exposure in underground potash or coal mines 
also found that measured lung function and symptoms were not associated with the 
cumulative NO2 exposure (Attfield et al., 1982; Robertson et al., 1984). The health 
effects of DE exposure have also been evaluated in farmers exposed to DE while 
working. The results showed that driving diesel tractors was associated with a duration 
dependent increase in odds ratio (OR) of wheeze (OR = 1.31, 95% confidential interval 
[CI] 1.13-1.52) comparing to driving gasoline tractors (OR = 1.11, 95% CI 1.02-1.21).  
 
Chronic Obstructive Phulmonary Disease (COPD) 
 
      COPD is a progressive syndrome of expiratory airflow limitation caused by chronic 
inflammation of the airways and lung parenchyma. Increasing in incidence, COPD is the 
fourth leading cause of death in the United States and also a leading cause of morbidity 
and mortality worldwide. Occupational exposure to respiratory silica and other inorganic 
dusts, has been associated with COPD (Hnizdo and Vallyathan, 2003; Bergdahl et al., 
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2004). Studies have also shown that exposure to vehicle motor exhaust may also 
contribute to the risk for morbidity and mortality of this disease. In a consecutive cross 
sectional study conducted during 1985-1994 in the Rhine-Ruhr Basin of Germany, 
Schikowski et al. (2005) reported that chronic exposure to PM10, NO2 and living near a 
major road might increase the risk of developing COPD and can have a detrimental effect 
on lung function in women. Women living less than 100 m from a busy road had an 
increased risk for COPD (1.79 times, 95% CI 1.06-3.02) and a significantly decreased 
lung function compared with those living farther away. In another cross sectional 
investigation, Ulvestad et al. (2000) studied the risk of COPD in 212 tunnel workers and 
a reference group of 205 other heavy construction workers in Norway. Compared with 
the reference subjects the tunnel workers had a significant decrease in FVC % predicted 
and FEV1 % predicted when related to years of exposure. Adjusted FEV1 decreased by 
17 ml for each year of tunnel work exposure compared with 0.5 ml in outdoor heavy 
construction workers. The tunnel workers also reported significantly higher occurrence of 
respiratory symptoms. The prevalence of COPD was 14% in the tunnel workers 
compared with 8% in the reference subjects. Other studies showed that occupational 
exposure to motor vehicle pollution or among construction workers only had a marginally 
increased prevalence or mortality of COPD (Fleming and Charlton, 2001; Bergdahl et al., 
2004). Recently Hart et al. (2006) recently reported a case-control study of railroad 
worker deaths between 1981 and 1982 which consisted of 536 cases with COPD and 
1,525 controls with causes of death not related to DE or fine particle exposure. After 
adjustment for age, race, smoking, U.S. Census region of death, vitamin use, and total 
years off work, engineers and conductors with DE exposure from operating trains were 
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found to have an increased risk of COPD mortality. The odds of COPD mortality 
increased with years of work in these jobs, and those who had worked 16 years or longer 
as an engineer or conductor after 1959 had an OR of 1.61 (95% CI, 1.12-2.30). These 
results suggest that DE exposure contributed to COPD mortality in these workers. 
 
Asthma 
 
       There has been a rapid increase in the prevalence of allergic diseases such as allergic 
asthma in the last decades. Asthma is a chronic respiratory disease manifested by 
bronchial hyperresponsiveness, reversible bronchial constriction, airway inflammation, 
and respiratory symptoms such as wheezing, dyspnea, coughing, and chest tightness 
(Busse et al., 2001). The increase in asthma and other allergic diseases has been a global 
phenomenon in industrial countries, which can not be attributed to genetic changes, but is 
assumed to be related to changes in environmental factors, including airborne PM, NOx, 
SO2, and ozone (Liccardi et al., 1998). DE, in addition to DEP, contains a complex 
mixture of gases such as CO, NOx, SO2, which may all contribute to the increased 
prevalence of asthma. Considering the health effects, recent focus has been on DEP, one 
of the major components of airborne PM in most urban and industrialized areas. 
 
      An early cross-sectional study has shown that the prevalence of cedar pollen allergy 
was higher near busy highways despite equivalent local exposure to cedar pollen in less-
busy areas (Ishizaki et al., 1987). This is among the earliest studies providing evidence on 
the relation between motor vehicle exhaust exposure and allergy. Since then, numerous 
epidemiological studies have shown associations between traffic density and prevalence 
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or morbidity of asthma. Observations have shown that children raised in more polluted 
regions of a country are more likely to develop respiratory diseases and allergies 
compared with children raised in “cleaner” regions (Heinrich et al., 1999). In Japan, 
studies have suggested that children living close to roads with heavy traffic are more 
likely to develop allergies (D'Amato et al., 1998). A Germany study showed that more 
than 3,700 adolescent students who were living on streets with “constant” truck traffic 
were 71% more likely to report symptoms of allergic rhinitis and more than twice were 
likely to report wheezing symptom (Duhme et al., 1996). Brauer et al. (2002) examined 
the relationship between traffic-related air pollution and the development of 
asthmatic/allergic symptoms and respiratory infections in a birth cohort (approximately 
4,000) study in The Netherlands. The results showed that the adjusted ORs for wheezing, 
physician-diagnosed asthma, ear/nose/throat infections, and flu/serious colds positively 
associated with concentrations of air pollutants (NO2, PM2.5, and soot). These data, 
however, could not distinguish the specific role of DE exposure in asthma morbidity from 
that of the other forms of exhausts. A few studies have been performed with 
consideration of the DE effects under urban exposure. A European panel study of 61 
children, of whom 77% were taking asthma medication, showed stronger associations for 
black smoke than for PM10 and ozone in relation to peak expiratory flow (PEF), 
respiratory symptoms, and bronchodilator use (Gielen et al., 1997). The authors 
hypothesized that black smoke may be a better surrogate for fine particles emitted by 
diesel engines or for the other chemicals that may be the causal components in DE. 
Oliver et al. (2001) reported that laborers, tunnel workers, and operating engineers who 
were exposed to DE in heavy and highway and tunnel construction were at increased risk 
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for asthma, of which tunnel workers also appeared to be at increased risk for chronic 
bronchitis. In a cross-sectional study of 76 DE-exposed dockers and 63 reference 
subjects, Mastrangelo et al. (2003) found that long-standing exposure of non-atopic 
dockers to DE at concentrations similar to those in heavily polluted cities increased 
serum IgE levels (OR = 11.4; 95% CI 1.44-526), but not the incidence of rhinitis or 
asthma. Moreover, none of the OR was significant among atopic individuals. However, 
Wade and Newman (1993) have described in a case report that three railroad workers 
who traveled in locomotive units right behind the diesel powered locomotive engine 
eventually developed asthma, which persisted 1-3 years. One individual's PEF rates fell 
in a work-related pattern when riding immediately behind the lead diesel engine. In two 
cases, physiologic abnormalities suggesting reversible restriction were observed. None 
had a previous history of asthma or other respiratory disease and none were smokers. 
This is the only report clearly implicating DE exposure as a cause of reactive airways 
disease, which was named “diesel asthma” by the authors.  
 
Lung Cancer 
 
       DE contains high concentrations of respirable carbonaceous particles with absorbed 
organic    and inorganic chemicals. Recognition that some of these compounds are 
mutagenic and carcinogenic agents has raised concern for the cancer-causing potential of 
DE exposure. DEP is known to cause lung cancer at least in rats (Mauderly et al., 1987) 
through chronic inhalation exposure. The combination of chemical data, genotoxicity, 
and experimental carcinogenicity has led the conclusion by National Institute for 
Occupational Safety and Health (NIOSH) that a potential carcinogenic hazard exist 
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amongst those exposed to DE (NOISH, 1988). The International Agency for Research on 
Cancer (IARC) to classify DE as a probable human carcinogen (IARC, 1989). Since then, 
extensive epidemiologic studies, mainly on lung cancers, among exposed workers have 
been conducted, and provided evidence that occupational exposure to diesel motor 
emissions may be associated with an increased risk in developing lung cancer. 
 
      There have been no fewer than a dozen of epidemilolgical reports demonstrated the 
risk of DEP-induced cancer in various workers (Garshick et al. 1987, 1988, 2004, 2006; 
Laden et al., 2006; Bunn et al., 2002, U.S. EPA, 2002; Saverin et al., 1999; California 
EPA, 1997; Steenland et al., 1998; Stayner et al., 1998). Boffetta and colleagues (Boffetta 
et al., 1988) showed that in U.S., railroad workers, heavy equipment operators, miners, 
and truck drivers had a higher mortality both for all causes and for lung cancer when 
compared with subjects with other occupations and no exposure to DE. Truck drivers 
exposed to DE were not at excess risk of lung cancer when compared with truck drivers 
unexposed to DE, but showed a trend of increasing risk with duration of exposure. 
Similar results have been also obtained in an investigation on the risk of lung cancer 
among male and female workers exposed to DE in a large record-linkage study.  In 
Sweden studies by Boffetta et al., (2001) showed that men exposed to DE in the 1960 
census experienced an increased risk of lung cancer with the RR of 0.95 (95% CI 0.9-
1.0), 1.1 (95% CI 1.1-1.2), and 1.3 (95% CI 1.3-1.4) for low, medium, and high intensity 
of exposure, respectively. The risk was higher for squamous cell carcinoma of the lung 
than for other histological types. In a 1979-1985 population-based case-control study 
conducted in Montreal, Canada, Parent et al. (2006) demonstrated that an increased risk 
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in lung cancer was associated with exposure to DE, after adjustments for potential 
confounders, but not with exposure to gasoline exhaust.  
 
      In total, these studies have established a relationship between DE exposure and lung 
cancer with various workers, including miners, railroad workers and professional drivers 
(e.g., trucks, buses, and taxies and found correlation between increased risk in cancer and 
duration of DE exposure.  
 
Cardiovascular Effects  
 
      Air pollution not only exerts respiratory effects, but also increases cardiovascular 
morbidity and mortality (Peters et al., 1999). Epidemiological studies have associated 
increased mortality in cardiovascular diseases with heavy air pollution (Dockery and 
Pope, 1994, Schwartz, 1994). Some recent studies have shown that exposure to 
particulate air pollution may increase the susceptibility to ischemic heart diseases (IHD) 
and the occurrence of myocardial infarction (Pekkanen et al., 2002; Peters et al., 2001; 
Zanobetti and Schwartz, 2005).  
 
      Several studies have linked the exposure to vehicle exhaust with various 
cardiovascular responses. In a cohort study by Hoek et al. (2002), the risk of death from 
cardiopulmonary causes in persons living close to a major road or highway was two times 
higher than those living farther from a major road or highway, after adjustment for risk 
factors such as age, sex, and smoking status (Hoek et al., 2002). Le Tertre et al. (2002) 
examined the association between airborne particles and hospital admissions for cardiac 
causes in eight European cities. The pooled percentage increases associated with a 10 
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µg/m3 increase in PM10 and black smoke were 0.5% (95% CI 0.2-0.8) and 1.1% (95% 
CI: 0.4 to 1.8) for cardiac admissions of all ages, 0.7% (95% CI 0.4-1.0) and 1.3% (95% 
CI 0.4-2.2) for cardiac admissions over 65 years, and, 0.8% (95% CI 0.3-1.2) and 1.1% 
(95% CI 0.7-1.5) for IHD over 65 years. Analysis of the effects of particulate air 
pollution on cardiac admissions suggested the primary effect was likely to be mainly 
attributable to DE.  In a retrospective cohort mortality study, Finkelstein et al. (2004) 
compared the risk of IHD mortality among heavy equipment operators to that of 
members of other construction unions. Two hundred fifty nine of 1,009 deaths among the 
heavy equipment operators were attributed to IHD, with a proportional mortality ratio of 
1.09 (95% CI 0.96-1.2). The mortality for IHD mortality, comparing the heavy 
equipment operators to all other workers combined was 1.47 (95% CI 1.17-1.84) for ages 
25-64, 1.20 (95% CI 0.96-1.50) for ages 65 or more, and 1.32 (95% CI 1.13-1.55) for all 
ages combined.  In a case control study by Gustavsson et al. (2001), the risk of 
myocardial infarction from occupational exposure to motor exhaust, other combustion 
products, organic solvents, lead, and dynamite was investigated. The RR of myocardial 
infarction was 2.11 (95% CI 1.23-3.60) among those who were highly exposed and 1.42 
(95% CI 1.05-1.92) among those who were intermediately exposed to combustion 
products from organic material. The other exposures were not consistently associated 
with myocardial infarction, while a possible association between exposure to dynamite 
and organic solvents with an increased risk was observed. A later case control study by 
the same group indicated that occupational exposure of professional drivers might 
contribute to their risk for myocardial infarction (Bigert et al., 2003). The crude ORs for 
myocardial infarction were 2.14 (95% CI 1.34-3.41), 1.88 (95% CI 1.19-2.98), and 1.66 
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(95% CI 1.22-2.26), among bus, taxi, and truck drivers. Adjustment for potential 
confounders gave lower but still increased ORs of 1.49 (95% CI 0.90-2.45), 1.34 (95% 
CI 0.82-2.19) and 1.10 (95% CI 0.79-1.53), respectively. The authors concluded that the 
work environment of these professional drivers might contribute to their increased risk 
for myocardial infarction. These studies indicated that environmental and occupational 
exposure to DE had adverse effects upon the cardiovascular system that increase risk of 
morbidity and mortality of cardiovascular diseases such as IHD and/or myocardial 
infarction.     
 
2.4 Experimental Studies 
 
Human Studies on DE Exposure and Asthma   
       Experimental studies using human subjects have shown that DEP induce airway 
inflammation, thus playing a role in the increase prevalence of allergic diseases. In a 
study by Salvi et al. (1999), fifteen healthy volunteers were exposed to a high 
concentration of DEP (300 µg/m3) in a chamber for 1 h.  At 6 h after exposure there was 
a significant increase in the number of neutrophils, mast cells, CD4+ and CD8+ 
lymphocytes in the airway mucosa, suggesting DEP may enhance inflammatory cell 
infiltration from blood vessel to the airway.  Furthermore, an elevated concentration of 
methyl-histamine was detected in the bronchoalveolar lavage (BAL) fluid, indicating an 
increased degranulation of mast cells. However, lung function was unaffected by DEP 
exposure in contrast to the increased inflammatory cell infiltration detected in the 
airways, suggesting that lung function measurements alone cannot be used to exclude 
adverse effect of DEP. Other similar studies using healthy nonsmoker volunteers exposed 
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to DEP (200-300 µg/m3) for 1-2 h also showed an inflammatory responses in the airways 
(Nordenhall, 2000; Nightingale et al., 2000).  
      Individuals with asthma have inflamed airways and are clinically more sensitive to air 
pollutants than control subjects. PM pollution adversely affects the airways, with 
asthmatic subjects thought to be especially sensitive. Several studies have been conducted 
to examine whether motor vehicle-derived air pollution or DE would promote asthmatic 
reactions in mild allergic asthma. In a study by Svartengren et al. (2000), volunteers with 
mild allergic asthma were exposed to air for 30 min in a city road tunnel or in a suburban 
area with much lower pollution levels. Although subjective symptoms during tunnel 
exposure were not pronounced, subjects exposed to tunnel NO2 levels at or higher than 
300 µg/m3 had a significantly greater early reaction following a low dose of allergen 
inhalation as well as lower lung function (FEV1) and more asthma symptoms during the 
late phase compared to controls. Also, subjects with PM2.5 exposure at or higher than 
100 µg/m3 had a slightly increased early reaction compared to controls. These data 
suggested that exposure to motor vehicle-derived air pollution may significantly enhance 
asthmatic reactions to subsequently inhaled allergens. In other studies on the effects of 
DE exposure on asthmatic reactions, Holgate and colleagues (Holgate et al., 2003; 
Stenfors et al., 2004) reported an increase in airway resistance of similar magnitude in 
both healthy and mild asthmatic subjects 2 h after exposed to ambient levels of DE. 
Healthy subjects, but not subjects with mild asthma, developed airway inflammation 6 h 
after DE exposure, with airways neutrophilia and lymphocytosis together with an 
increase in interleukin (IL)-8 protein in BAL fluid, bronchial mucosa and upregulation of 
the endothelial adhesion molecules, suggesting low level DE exposure did not induce a 
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neutrophilic response or exacerbated their pre-existing eosinophilic airway inflammation 
(Holgate et al., 2003). When the asthmatic subjects were exposed to high concentration of 
DE, however, worsen lung function and asthmatic responses were noted by the same 
group (Nordenhall et al., 2001).  In this study, fourteen atopic asthmatics with stable 
disease and on continuous treatment with inhaled corticosteroids were exposed to DE 
(300 µg/m3 PM10) for 1 h. Exposure to DE was associated with a significant increase in 
airway resistance immediately after the exposure and the degree of hyperresponsiveness 
to methacholine at 24 h after exposure, compared to air control subjects. These studies 
indicated that short-term exposure to high levels of DE is associated with adverse effects 
in asthmatic airways, even in the presence of inhaled corticosteroid therapy.  
 
      DEP have been shown to potentiate IgE production in human respiratory mucosal 
membranes or even lead to primary sensitization of humans by driving a de novo mucosal 
IgE response. A human nasal challenge study was performed in which human subjects 
were exposed to various doses of DEP to investigate the effect of DEP on the production 
of localized immunoglobulins. Four days after challenge with 0.3 mg DEP, increased 
production of IgE but not other immunoglobulins was detected (Diaz-Sanchez et al., 
1994). Studies have also shown that DEP may have an adjuvant effect to allergens on 
human subjects.  Ragweed-sensitive individuals were exposed to 0.3 mg DEP and 
ragweed. Ragweed challenge alone enhanced the production of IgE, IgG4, and also 
allergen-specific IgE in the BAL fluid. However, in DEP and ragweed combined exposed 
group, there was a 16-fold increase in ragweed-specific IgE. Although DEP alone 
enhanced total IgE, it was the combination of DEP and ragweed that led to an increased 
production of ragweed-specific IgE and an increased expression of T helper type 2 (Th2) 
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cytokines (Diaz-Sanchez et al., 1994). Data from these human studies suggested that DEP 
may play a role in the increase prevalence of allergic diseases by enhancing Th2 
responses and IgE production. In another study, Diaz-Sanchez et al. (1999) examined the 
ability of DEP exposure to lead to primary sensitization of humans. Atopic subjects were 
immunized with a neoantigen keyhole limpet hemocyanin (KLH) and DEP were 
administered 24 h before each KLH exposure. Exposure to KLH alone led to the 
generation of an anti-KLH IgG and IgA humoral response, which was detected in nasal 
fluid samples. In contrast, when challenged with KLH preceded by DEP, 9 of the 15 
subjects produced anti-KLH-specific IgE. KLH-specific IgG and IgA at levels similar to 
that seen with KLH alone could also be detected. Subjects who received DEP and KLH 
had significantly increased IL-4, but not interferon (IFN)-γ, in nasal lavage fluid, whereas 
these cytokines were unchanged in subjects receiving KLH alone. These studies 
demonstrated that DEP can not only potentiate IgE production in human respiratory 
mucosal membranes, but also act as mucosal adjuvant to a de novo IgE response and may 
increase allergic sensitization. 
 
Human Studies on DE Exposure and Cardiovascular Diseases 
 
      Human studies suggested that PM has the potential to affect important cardiovascular 
parameters. It has been shown that acute exposure to air pollution resulted in increased 
plasma viscosity (Peters et al., 1997) and increased infiltration of inflammatory cells in 
the blood (Salvi et al., 1999). Ultra-fine particles were shown to provoke alveolar 
inflammation with release of mediators capable of causing exacerbations of lung disease 
and of increasing blood coagulability in susceptible individuals, thus explaining the 
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observed increases in cardiovascular deaths associated with urban pollution episodes 
(Seaton et al., 1995). Another report showed that exposure to PM led to changes in 
haemoglobin concentration, haematocrit and red blood cell counts and decreased platelet 
number and fibrinogen levels (Seaton et al., 1999). Peters et al. (2004) conducted a case-
crossover study to assess whether exposure to traffic can trigger myocardial infarction. 
An association was found between exposure to traffic and the onset of a myocardial 
infarction within one hour afterward (OR = 2.92; 95% CI 2.22-3.83). The time the 
subjects spent in cars, on public transportation, motorcycles, or bicycles was consistently 
linked with an increase in the risk of myocardial infarction. The subject's use of a car was 
considered to be the most common source of exposure to traffic, while the time spent on 
public transportation was associated with the onset of a myocardial infarction one hour 
later. These results showed that transient exposure to traffic might increase the risk of 
myocardial infarction in susceptible persons. A recent human study further showed that 
compared to air controls, short-term inhalation exposure of healthy men to DE, at levels 
encountered in an urban environment, impairs the regulation of vascular tone and 
endogenous fibrinolysis, two important and complementary aspects of vascular function 
in humans (Mills et al., 2005). These important findings provide a potential mechanism 
that links DE to the pathogenesis of atherothrombosis and acute myocardial infarction. 
 
Modulation of the Pulmonary Immune Responses  
 
      In recent years, ambient air pollution has been associated with hospitalizations and 
deaths due to exacerbations of cardiovascular and respiratory diseases (Samet, 2000). 
Increasing evidence shows that DEP may exert a strong modulating effect on the 
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pulmonary immune system.  Particularly, DEP and other particulate air pollution have 
been linked to asthma (Norris et al., 1999; Lipsett et al., 1997; D'Amato, 1999). DEP can 
act as nonspecific airway irritants at relatively high levels. At lower levels, DEP promote 
release of specific cytokines, chemokines, immunoglobulins, and reactive oxygen species 
(ROS), which are central chemical messengers in the inflammatory processes of asthma. 
Release of these mediators of the allergic and inflammatory response initiates a cascade 
that can culminate in airway inflammation, mucus secretion, serum leakage into the 
airways, and bronchial smooth muscle contraction (Pandya et al., 2002). In addition, 
modulation of the pulmonary immune responses by DEP is also directly associated with 
their adverse effect on pulmonary infections (Yang et al, 2001; Yin et al., 2002, 2003, 
2004a, 2004b, 2005, 2006).   
 
      The cytotoxicity and immune-modulating effects of DEP have been examined in a 
number of studies using human bronchial and nasal epithelial cells. DEP exposure led to 
cell membrane damage in a dose- and time-dependent manner. Transmission electron 
microscopy study showed that DEP underwent endocytosis and translocated into 
epithelial cells (Boland et al., 1999). When the nasal or bronchial epithelial cells were 
exposed to DEP, their synthesis and release of proinflammatory cytokines such as IL-1, 
IL-6, IL-8, adhesion molecules, and granulolcyte-macrophage colony-stimulating factor 
(GM-CSF), were significantly increased (Devalia et al., 1997; Boland et al., 1999). Study 
found that carbon black (CB) particles, which resembled the carbonaceous core of DEP, 
had no effect on cytokine release, suggesting the cytokine effect appeared to be attributed 
to the adsorbed organic compounds (Boland et al., 1999). Furthermore, DEP were shown 
to induce the degranulation of eosinophils and enhance their adhesiveness to epithelial 
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cells without changing the eosinophils survival rate, suggesting that DEP are likely to 
play an important role in promoting nasal hypersensitivity induced by increased 
eosinophil infiltration and degranulation (Terada et al., 1997). In a recent study, 
Mamessier et al. (2006) assessed the effect of DEP on the activation of T-cells, the main 
cells orchestrating asthma inflammation. The study showed that DEP could activate T-
cells in asthmatics only, with a higher effect occurring during exacerbations.  
 
      IL-8, a member of CXC chemokine family mainly produced by macrophages, is one 
of the key mediators in attracting neutrophils to the airways (Lezcano-Meza et al., 1999).  
Since neutrophils are the most important inflammatory leukocytes in airway secretions of 
patients with acute severe asthma (Ordonez et al., 2000), the effect of DEP on the 
secretion of IL-8 is significant. In a study by Bayram et al. (1998a), DEP exposure 
attenuated the ciliary beat frequency of human bronchial epithelial cells and increased 
their release of IL-8, GM-CSF, and soluble intercellular adhesion molecule (ICAM)-1. 
Increased production of IL-8 was also observed in bronchial washings and bronchial 
tissues of healthy human volunteers after exposure to DEP (Salvi et al., 2000). In another 
study, the effects of DEP on the production of IL-8 by cultured human bronchial cells 
were compared between healthy volunteers and atopic patients with mild asthma. There 
was a significant increase in the levels of IL-8 in the bronchial cells from asthmatic 
patients when they were treated by 10 µg/ml DEP. In the cells from nonasthmatics, only 
higher concentrations of DEP (50 and 100 µg/ml) caused an increase in the release of IL-
8. The results indicated that the bronchial cells from asthmatic patients were more 
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sensitive to DEP than those from nonasthmatics and that the DEP-mediated IL-8 
production may play a role in asthmatic responses (Bayram et al., 1998b).  
 
      DEP may also promote expression of the Th2 immune response phenotype that has 
been associated with asthma and allergic disease. Many kinds of cytokines stimulate B 
cells and T cell switching to the Th2 subtype, attract and prolong the infiltration and 
survival of eosinophils, and increase local IgE production, resulting in allergic or 
asthmatic response. IL-4, for example, is a Th2 cytokine which induces isotype switching 
of B cells in antibody production from IgM to IgE. IL-5, on the other hand, is important 
for the proliferation and activation of eosinophils after exposure to some types of 
allergens such as pollen and OVA (Miyabara et al., 1998). In a study by Diaz-Sanchez et 
al. (1996), healthy, nonsmoking human volunteers were exposed to DEP and mRNA 
expression for cytokines in nasal lavage was examined. Before challenge, most 
individuals had detectable mRNA levels of only a few cytokines (IFN-γ, IL-2 and IL-13). 
However, after challenge with 0.3 mg DEP, these three cytokines and a number of 
additional kinds (IL-4, IL-5, IL-6 and IL-10) were measured in increasing levels (Diaz-
Sanchez et al., 1996). Furthermore, DEP have been shown to enhance Th2 cytokine 
production more efficiently when combined with an allergen than exposure to an allergen 
or DEP alone. Exposure of mice to DEP with OVA markedly increased local IL-4 and 
IL-5 levels compared with either antigen or DEP alone (Takano et al., 1997).  In a human 
study, Diaz-Sanchez et al. (1997) also showed that healthy human individuals exposed to 
DEP together with ragweed antigen had higher levels of IL-5 production in nasal lavage 
fluid than those exposed to DEP alone.  
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      One of the important effects of DEP on modulation of the immune responses is 
thought to increase IgE synthesis, thus facilitating allergic sensitization in atopic subjects 
and the subsequent development of clinical respiratory symptoms. IgE is produced by 
activated B cells in response to a specific allergen. Once produced IgE attaches to mast 
cells and, when cross-linked by allergen, induces mast cells to release histamine and 
leukotrienes. The chemicals released from mast cells cause constriction of bronchial 
smooth muscle, mucus secretion, and serum leakage into the airways and result in acute 
asthma symptoms (Busse, 2001). The mast cell is often considered the central cell type in 
the acute asthmatic response, and IgE is the critical immunoglobulin driving the mast cell 
response. Extensive studies have been conducted to demonstrate that DEP, the organic 
compounds of DEP, as well as other physical particles may enhance IgE production, 
either alone or acting as an adjuvant to allergens (Takafuji et al., 1987; Takenaka et al., 
1995, Diaz-Sanchez et al., 1996; Takano et al., 1997; Dong et al., 2005a, 2005b).  It has 
been suggested that DEP may enhance IgE production by activating B cells through 
inducing Th2 cytokines. One study showed that when human B cell was stimulated by 
IL-4, the IgE production was significantly increased after exposure to phenanthrene, a 
major polyaromatic hydrocarbon and one of the most important DEP components (Tsien 
et al., 1997). 
 
      While DEP enhance the Th2 responses to allergic sensitization, the same particles 
have been also shown to suppress the host defense mechanism against bacterial infection, 
which may contribute to the etiology of air pollution-associated pulmonary diseases such 
as infections of the upper and lower respiratory tract. Animal studies conducted in our 
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laboratory consistently demonstrate that DEP exposure suppresses both the innate, 
orchestrated by alveolar macrophages (AM), and T-cell mediated immune responses, 
resulting in an increased susceptibility of the lung to bacterial infection (Yang et al, 2001; 
Yin et al., 2002, 2003, 2004a, 2004b, 2005).  DEP were shown to inhibit L. 
monocytogenes-induced AM production of IL-1β and tumor necrosis factor (TNF)-α, 
which are responsible for the innate immunity, and IL-12, which initiates the 
development of Th1 responses, but enhance L. monocytogenes-induced AM production 
of IL-10, which prolongs survival of the bacteria in these phagocytes. On the other hand, 
DEP exposure also suppressed the development of bacteria-specific lymphocytes from 
lung-draining lymph nodes, as indicated by the decreased numbers of T lymphocytes and 
their CD4+ and CD8+ subsets. Cytokine production by lymphocytes from DEP-exposed 
and L. monocytogenes-infected rats showed a marked decrease in the production of IL-2 
and IFN-γ compared to bacterial infection alone, suggesting that either DEP inhibit the 
production of cytokines by lymphocytes or these lymphocytes contained T cell subsets 
that are different from those of bacterial infection alone and less effective in mediating 
Th1 immune responses (Yin et al., 2003, 2004a, 2005).  In vitro studies further showed 
that DEP or organic extracts of DEP, but not washed DEP or CB, dose-dependently 
suppressed L. monocytogenes-induced secretion of TNF-α, IL-1β, IL-12 by AM and IL-2 
and IFN-γ by lymphocytes obtained from L. monocytogenes-infected rats, but augmented 
the AM secretion of IL-10. Parallel to the alterations in cytokine secretion, DEP or 
organic extracts of DEP, but not washed DEP or CB, significantly decreased the 
phagocytotic and bacterial killing activities of rat AM (Yin et al., 2006). These results 
provide direct evidence that DEP, through the actions of organic components, suppresses 
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AM immune functions against bacterial infection. Inhibition of AM phagocytic function 
and alterations of AM and lymphocyte cytokine secretion by DEP and DEP organic 
compounds may be implicated in the diminished AM bactericidal activity and the 
lymphatic arm of the host immune system, thus resulting in an suppressed pulmonary 
clearance of pathogens and increased susceptibility of the lung to infection.  
 
Biomarker Studies   
 
      In recent years, studies have been carried out that have led to the discovery of 
biological and biochemical markers, which are increasingly valuable for predicting and 
preventing diseases with environmental etiology, including biomarkers of exposure, 
effect, and susceptibility for DE.  In most of the human biomarkers studies, DNA from 
peripheral blood/leukocytes or other cells/tissues are used to evaluate the genotoxicity of 
DE exposure. Pohjola et al. (2003) have examined diesel-derived PAH binding to DNA 
and compared the differences in DNA adduct forming capacity of diesel- and gasoline-
derived PAH in human bronchial epithelial cells. The levels of DNA adducts were in 
good accord with the 10 DNA adduct-forming PAH concentrations analyzed in the 
extracts of particulates form both exhausts. SRM 1650, a standard material for DEP, 
dose-dependently formed DNA adducts in the cells, which was about 11- and 31-fold 
more than gasoline engine exhaust, when PAH-DNA adduct levels were calculated on an 
emission basis (adducts/mg PM/km) (Pohjola et al., 2003). Studies have also shown an 
increased formation of 8-hydroxy-2'-deoxyguanosine (8-OHdG) in peripheral blood 
lymphocytes and altered antioxidant capacities in serum and red blood cells of coal 
miners (Schins et al., 1995, 1999).  Kuusimaki et al. (2004) have assessed and evaluated 
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the biomarkers of exposure to DE in bus-garage and waste-collection workers. In the 
seven measured urinary PAH metabolites including 2-naphthol, 1-hydroxyphenanthrene, 
2-hydroxyphenanthrene, 3-hydroxyphenanthrene, 4-hydroxyphenanthrene, 9-
hydroxyphenanthrene and 1-hydroxypyrene (1-OH-P), the concentrations of 1-OH-P and 
2-naphthol and the sum of seven urinary PAH metabolites were higher in the exposed 
group than in the control group. In addition, increased O(6)-alkylguanine DNA adducts 
were detected in the white blood cells of underground workers, suggesting higher 
exposure to nitroso-compounds (Scheepers et al., 2002).  
 
      Xenobiotic metabolizing enzymes, especially cytochrome P450 (CYP) 1A1 and 
GSTM1, are involved in the activation and conjugation of PAHs and are controlled by 
polymorphic genes. In the biomarker of susceptibility studies, Adonis et al. (2003) 
therefore connected DE exposure with CYP1A1 and GSTM1 and studied the contribution 
of CYP1A1 and GSTM1 polymorphisms on 1-OH-P urinary levels used as the PAH 
exposure biomarker. They studied 59 diesel exposed (38 diesel revision workers and 21 
subjects working in an urban area as established street vendors) and 44 non-exposed 
subjects living in a rural area. When 1-OH-P levels were related with genotypes, an 
association was observed for the CYP1A1 2A genotype, so that the diesel-exposed 
workers carrying the CYP1A1 2A allele showed significantly higher 1-OH-P levels than 
the subjects from the rural area with the same genotype. On the other hand, there was no 
significant correlation between urinary 1-OH-P levels and GSTM1 null genotype, 
although higher levels of the urinary metabolite were found in individuals carrying the 
combined CYP1A1 2A and GSTM1 null genotype. These results suggested an 
association between levels of the exposure biomarker 1-OH-P and presence of the 
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CYP1A1 2A genotype, a potential genetic susceptibility biomarker which might be useful 
in identifying individuals at higher risk among people exposed to high PAH levels in DE.  
 
      Since benzene, a component of DE, causes alterations in porphyrin metabolism, and 
some of these may lead to the formation of tumors, heme synthesis is proposed as a 
biomarker of early health effects of DE. Muzyka et al. (2002) have investigated the levels 
of 5-aminolevulinic acid (ALA) and protoporphyrin (PP), activities of ALA synthase and 
ferrochelatase, as well as levels of PP associated with DNA (PP/DNA) in lymphocytes 
from workers exposed to DE at a marine diesel fuel terminal. Levels of ALA, PP, and 
ALA-synthase activity were significantly increased in marine terminal workers. At the 
same time ferrochelatase activity was decreased compared to unexposed controls. In an 
investigation carried out at a coal mine and at an oil-shale mine, Muzyka et al. (2003, 
2004) reported that the values of PP and PP/DNA in lymphocytes appeared to be 
significantly increased only in miners in the oil-shale mine. There was no difference in 
the levels of PP and PP/DNA and ferrochelatase activity between surface workers and 
miners at the coal mine. The level of heme in lymphocytes of coal mine miners was 
significantly higher than in miners of the oil-shale mine. The activity of ferrochelatase 
was significantly lower in underground workers compared to surface workers at this 
mine. These studies suggested that alterations of porphyrin and heme metabolism in 
peripheral lymphocytes might serve as biomarker in assessment of exposure to DE 
effects. In addition, Knudsen et al. (2005) have shown that DNA damage in frozen blood 
samples was significantly higher in underground workers driving diesel-powered 
excavation machines than surface workers. 
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Mechanisms of DEP-Induced Pulmonary Responses 
 
      Although extensive studies have been conducted, the mechanisms by which DE 
exerts its adverse health effects have not yet been fully understood.  This may be at least 
partially due to the complex physical and chemical features of DE composition. 
However, emerging data suggest a key role for DEP-induced oxidative stress in their 
health effects. DEP or the organic DEP components have been shown to induce 
production of ROS in a variety of  cell types, which have been involved in the 
pathogenesis and development of many different health conditions and are likely to be 
responsible for the adverse effects of DEP on the cardiopulmonary system, including 
lung cancer, asthma, COPD, and cardiovascular diseases. This review, rather than 
attempting to review all available data on mechanistic studies, highlights those that aid 
our understanding of the role of ROS in DE-induced adverse effects. 
 
      Studies have shown that the particulate component of DEP elicits respiratory burst 
activity of inflammatory cells, such as AM and neutrophils in the production of ROS and 
proinflammatory cytokines. The organic components of DEP,  such as PAHs and 
quinones, on the other hand, have been shown to produce intracellular ROS in AM 
through interaction with metabolizing enzymes such as CYP1A1 (Ma and Ma, 2002; 
Baulig et al., 2003; Yin et al., 2004b). PAHs are converted to quinones via 
biotransformation involving CYP1A1, expoxide hydrolase, and dihydrodiol 
dehydrogenase (Penning et al., 1999). Quinones act as catalysts to produce ROS and may 
be key compounds in PM toxicity along with transition metals (Penning et al., 1999; 
Monks et al., 1992). Redox cycling of quinones undergoes one-electron reductions by 
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NADPH cytochrome P450 reductase to form semiquinones (Monks et al., 1992), which 
can be recycled to the original quinones, leading to the formation of superoxide. 
Transition metals, such as Fe, Ni, Cu, Co and Cr are also important in ROS generation 
through the Fenton and Haber-Weiss reactions (Kehrer et al., 2000). It is possible that 
transition metals may synergize with organic PM components in ROS generation (Stearns 
et al., 2002). 
 
      An imbalance between the production of ROS and antioxidant capacity leads to a 
state of oxidative stress that contributes to the pathogenesis of a number of human 
diseases including those of the lung by damaging lipids, protein, and DNA. The 
genotoxicity of DEP may be mediated by ROS, although it may be caused by direct 
(primary) actions of PAHs, which are known to be genotoxic in vivo and capable of 
forming DNA adducts (Tsurudome et al., 1999; Arlt et al., 2001). Indeed, ROS has been 
shown to be genotoxic and proliferating substances that lead to tumor formation 
(Oberdorster, 1995; Oberdorster, 1997; Borm et al., 1996; Morrow et al, 1996). ROS are  
able to induce oxidation of DNA bases, DNA strand breaks, or lipid peroxidation-
mediated DNA adducts (Kasai et al, 1986; Schraufstatter et al., 1988; Aruoma et al., 
1989; Trush et al., 1991). In vivo studies have shown that the 8-hydroxyguanine levels in 
rat lung DNA increased markedly at an early phase after DEP exposure, by the 
generation of ROS and the inhibition of 8-hydroxyguanine repair activity (Tsurudome et 
al., 1999). These studies indicated that the ROS produced after DEP exposure may play 
an important role in the genotoxicity and carcinogenicity of DEP.  
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      An important mechanism of DEP mediated pulmonary responses involves the 
generation of ROS and depletion of the antioxidant capacity in lung cells. Li et al. (2002) 
demonstrated that the organic DEP extract induces a stratified oxidative stress response, 
leading to heme oxygenase 1 (HO-1) expression at normal reduced 
glutathione/glutathione disulfide (GSH/GSSG) ratios and that the activation of Jun kinase 
and IL-8 production at intermediary oxidative stress levels culminated in cellular 
apoptosis in parallel with a sharp decline in GSH/GSSG ratios. Whitekus et al. (2002) 
also showed that DEP induced an oxidative stress as indicated by a decrease in 
intracellular GSH/GSSG ratios and protein and lipid oxidation in vitro, which could be 
blocked by the thiol antioxidants, bucillamine (BUC) and N-acetylcysteine (NAC). They 
further demonstrated that NAC and BUC effectively inhibited the generation of lipid 
peroxidation and protein oxidation in the lungs and the adjuvant effects of DEP in the 
induction of OVA-specific IgE and IgG1 production in OVA- plus DEP-exposed 
animals. These results showed that DEP may alter allergic responses, which are at least 
partially, attributed to the DEP-induced oxidative stress in AM and epithelial lung cells.  
 
      In fact, ROS has been implicated in the etiology and pathogenesis of allergic asthma. 
ROS can reproduce many of the athophysiological features of asthma including enhanced 
arachidonic acid release, airway smooth muscle contraction, increased airway reactivity 
and secretions, increased vascular permeability, and increased synthesis of 
chemoattractants Owen et al., 1991; Sadeghi-Hashjin et al., 1996). ROS-mediated injury 
to the epithelium produces hyperresponsiveness of human peripheral airways, suggesting 
that ROS may play a role in the pathogenesis of asthma (Hulsmann et al., 1994). 
Neutrophils isolated from peripheral blood of asthmatic patients can generate greater 
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amounts of superoxide and H2O2, and their ability to produce superoxide correlates with 
the degree of airway hyperresponsiveness to inhaled methacholine (Seltzer et al., 1986; 
Hiltermann et al., 1998). Inflammatory cells obtained from asthmatic patients, 
particularly eosinophils, which produce more superoxide than neutrophils or 
macrophages, release ROS at baseline and after stimulation ex vivo (Sedgwick et al., 
1990; Sanders et al., 1995). This suggests that the biochemical milieu in asthma contains 
factors which may prime ROS generation in vivo. Eosinophils play a critical role in 
asthma because their increased presence in BAL fluid and blood is closely linked with 
bronchial hyperresponsiveness (Foreman et al., 1999; Wood et al., 2000). BAL fluid 
eosinophils, AM, and neutrophils from asthmatic patients produce more ROS than do 
those from normal subjects (Teramoto et al., 1996; Schauer et al., 1991). ROS directly 
contract airway smooth muscle preparations and this effect is enhanced when the 
epithelium is injured or removed. This observation might provide a mechanistic link 
between epithelial injury arising from a variety of causes and airway hyperresponsiveness 
(Hulsmann et al., 1994). ROS also appear to directly stimulate histamine release from 
mast cells and mucus secretion from airway epithelial cells (Krishna et al., 1998). In 
addition, there is also increasing evidence showing that oxidative stress has been 
proposed in the pathogenesis of many other conditions such as pulmonary infection, 
COPD and cardiovascular diseases (Yin et al., 2004b; Langen et al., 2003; Rahman, 
2005; Tao et al., 2003; Hirano et al., 2003). For example, Yin et al. (2004b) have shown 
the role of ROS in modulation of the AM-mediated immune responses to L. 
monocytogenes by DEP. Exposure of L. monocytogenes-infected AM to DEP or their 
organic extracts resulted in an increased expression of intracellular ROS and HO-1, 
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followed by an increased secretion of IL-10 but decreased secretion of TNF-α and IL-12 
from the cells.  Interestingly, direct stimulation of the AM with pyrogallol, a superoxide 
donor, up-regulated HO-1 and IL-10 but decreased secretion of IL-12. This study 
provides direct evidence that DEP mediated ROS response exerts a modulating effect on 
immune responses against bacterial infection, causing a switch of immune response from 
Th1 to Th2, thereby enhances both respiratory infection and allergic asthma. 
 
      At least two well-known classes of transcription factors, the nuclear factor-κB (NF-
κB) and the activator protein-1 (AP-1) families, are regulated by the intracellular redox 
state (Pinkus et al., 1996). Expression of cytokine genes is controlled by transcription 
factors, which interact with specific sequence motifs in the promoter region of the gene. 
Particularly, NF-κB plays a key role in regulation of the expression of various genes 
involved in the inflammatory and immune response (Jany et al., 1995). NF-κB activation 
requires cytosol dissociation of the inhibitory subunit IκB from the NF-κB protein 
complex, allowing its nuclear translocation and binding to DNA consensus sites. A 
particular IκB-α kinase complex phosphorylates IκB, resulting in its rapid ubiquitation 
and subsequent degradation by the proteasome (Zandi et al., 1997).  
 
      Studies have shown that DEP activate several signaling pathways,  such as mitogen-
activated protein kinases (MAPK) and transcription factors, in particular NF-κB in 
human bronchial epithelial cells (Hashimoto et al., 1999; Marano et al., 2002; Takizawa 
et al., 2003). Electronphoresis mobility assays have shown that DEP exposure may 
enhance the binding of NF-κB to DNA in airway epithelial cells (Baeza-Squiban, 1999; 
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Takizawa et al., 1999).  Furthermore, transient transfection experiments with a construct 
containing NF-κB binding DNA consensus sites concluded that DEP might induce the 
activation of NF-κB-dependent gene transcription (Takizawa et al., 1999). Although no 
data exist for the activation of AP-1 by DEP, evidence showed that β-naphthoflavone (β-
NAF), a prototype of PAH, and a derivative tert-butylhydroxyquinone (tBHQ), a 
prototype quinone, might induce AP-1 electrophoretic mobility shift complexes in 
macrophage cell lines (Ng et al., 1998).  Ng et al. reported that β-NAF and tBHQ induced 
the activity of the N-terminal jun kinase (JNK) MAPK cascade. This cascade, which is 
involved in the transcriptional activation and expression of c-Jun and serves to regulate 
different aspects of AP-1 transcriptional activity, can be induced by various kinds of 
injurious chemicals and cellular stress inducers, including genotoxic chemicals, 
inflammatory cytokines, and H2O2 (Kyriakis et al., 1994). These data indicated that DEP 
and DEP-derived PAHs and their quinone derivatives could induce the activation of 
MAPK cascades as well as transcription factors NF-κB and AP-1. These effects were 
also dependent on the role of ROS. Studies have shown that the release of DEP-induced 
cytokines and the activation of MAPK and NF-kB were significantly inhibited by 
antioxidants (such as NAC), indicating that ROS was strongly incriminated in these DEP 
effects (Hashimoto et al., 2000; Marano et al., 2002; Baulig et al., 2003; Takizawa et al., 
2003). 
 
      In addition to the adjuvant effect, DEP can also induce IgE production by acting 
directly on B cells. Takenaka et al. (1995) demonstrated that the organic DEP extract of 
PAHs enhanced human IgE production from purified B cells. Additionally, the pattern of 
 39 
mRNAs coding for distinct isoforms of the ε chain was altered by PAH-DEP, and B-cell 
expression of the low-affinity IgE receptor was upregulated by PAH-DEP. Studies by 
other investigators have also indicated that the organic extract of DEP (PAH-DEP) and 
particularly, phenanthrene, a major component of DEP, consistently enhanced IgE 
production by 2C4/F3, a human Epstein-Barr virus transformed isotype switched , IgE 
producing B cell line (Tsien et al., 1997). Enhanced IgE production in the human airway, 
resulting from exposure to PAH-DEP, may be an important factor in the increase in 
airway allergic disease. 
 
2.5 Summary 
 
       Ample studies have indicated that DE, at levels occurring in both ambient and 
occupational settings, exerts adverse health effects on humans. There is a general 
agreement in the scientific community that exposure to relatively high levels of DE are 
likely to cause lung cancer in humans, although contradiction exists which challenge the 
notion that DE is a probable human carcinogen (Bunn et al., 2002, 2004; Hesterberg et 
al., 2005). DEP exposure is also associated with a number of non-specific lung diseases 
including pulmonary bacterial infection and allergic asthma. 
 
Epidemiology data further linked DE exposure with excess risk for respiratory 
symptoms, reduced lung function, COPD, and cardiovascular diseases in humans. Both 
the organic and particulate components of DEP have been shown to play a role in 
modulating the immune inflammatory responses and the induction of genotoxicity. 
Allergic asthma is a complex disease which involves B cell production of allergen-
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specific antibodies that leads to eosinophil infiltration and airway inflammation resulting 
in obstructive airway disease through enhanced Th2 immunity. 
 
 The production of ROS by lung cells (including AM and type II cells) which result in 
oxidative stress is considered a key factor responsible for the adverse DEP effects. The 
literature suggests that DEP may alter pulmonary immune responses through multiple 
pathways that include enhanced Th2 immunity, induction of airway inflammation 
through direct effect on epithelial cells, and systemic effect on B cell responses. Because 
of the multiple pathways, it is likely that the relative timing of DEP exposure and allergen 
sensitization may play a role in DEP-mediated allergic asthma. 
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3. MATERIALS AND METHODS  
 
3.1 Animals and Exposure Schedule 
 
       Male Brown Norway rats [BN/CrlBR] weighing 200-225 g were obtained from 
Charles River Laboratories (Wilmington, MA). The animals were housed in a clean-air 
and virus-free room with restricted access, given a conventional laboratory diet and tap 
water ad libitum, and allowed to acclimate for 1 week before use in an animal facility 
approved by the Association for Assessment and Accreditation of Laboratory Animal 
Care. 
 
OVA Immunization.  
 
      A solution of OVA (Grade V, Sigma Chemical Co., St. Louis, MO) in endotoxin-free 
saline (1%) was aerosolized using a DeVilbiss-646 nebulizer (DeVilbiss, Somerset, PA). 
To achieve the desired concentration, filtered air was passed through the nebulizer and 
used as a diluent for the aerosolized OVA. The concentration of OVA in the chamber was 
determined by collecting samples onto 0.4 µm filters (Polycarbonate Membrane, Poretics 
Corporation, Livermore, CA) from a chamber side port at a rate of 1 l/min. Filters were 
washed with 10 ml of endotoxin-free saline and analyzed for protein using the Coomassie 
blue dye reagent (Bio-Rad Laboratories, Hercules, CA). Rats were sensitized to OVA at 
an average chamber concentration of 42.3 ± 5.7 mg/m3 for 30 min on days 1, 8, and 15, 
and challenged with OVA on day 29 (protocol A). The animals were subjected to whole-
body plethysmography on day 30, 24 h after the last OVA dose, and they were sacrificed 
on day 31 for biochemical and cellular measurements (protocol B). Nonsensitized 
 42 
animals were exposed to aerosolized endotoxin-free saline following the same exposure 
schedule. 
 
DEP Exposure.   
 
 a. Protocol A and B. 
 
     A standardized DEP sample (standard reference material 2975), representing heavy-
duty diesel engine with a mass median aerodynamic diameter of 0.5 µm, was purchased 
from the National Institute of Standards and Technology (Gaithersburg, MD). Diesel 
exhaust particles were suspended in endotoxin-free sterile saline (Baxter Healthcare 
Corporation, Deerfield, IL), followed by sonication for 2 min in an ultrasonic processor 
with a micro tip (Heat System-Ultrasonics, Plainview, NY) prior to use. The DEP 
inhalation exposure system used in this study has been described and characterized 
elsewhere (Yin et al., 2002, 2004a). Rats were exposed to either filtered air or DEP (22.7 
± 2.5 mg/m3), 4 h/day for 5 consecutive days either prior to the sensitization  from day -4 
to day 0 (protocol A)  or on days 24-28 of the sensitization process (protocol B), 24 h 
prior to the last (challenge) dose of OVA using a nose-only directed flow exposure unit 
(CH Technologies, Inc., Westwood, NJ). The DEP concentration in the exposure unit was 
monitored by both gravimetric sampling of dust collected on a polycarbonate membrane 
filter (37 mm, 0.45 µm, Poretics Corporation, Livermore, CA) at a sampling rate of 1 
l/min, and with a Grimm Model 1.108 portable dust monitor (GRIMM Technologies, 
Inc., Douglasville, GA), which allows continuous measurement of the particle 
concentration in the exposure unit in real time. The estimated mean lung deposition of 
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DEP for the above-described inhalation exposure, calculated based on the method of 
Leong et al. (1998), was 402 ± 58 µg/rat. 
 
      The exposure groups (5 rats/group) for the present study were: nonsensitized/ air-
exposed/saline challenged (saline + air); non-sensitized/DEP exposed/ saline challenged 
(saline + DEP); OVA-sensitized/air-exposed/OVA challenged (OVA + air); and OVA-
sensitized/DEP-exposed/OVA challenged (OVA + DEP). All parameters were measured 
after saline/OVA challenge (the last dose) with and without DEP exposure. 
 
b. DEP by Intratracheally Instillation (i.t.) 
 
      Rats were anesthetized with sodium methohexital (35mg/kg intraperitoneally) and 
placed on an inclined restraint board. A 0.3-ml suspension of DEP at a dose of 35mg/Kg 
body weight, or equivalent amount of saline (control) was intratracheally instilled. Rats 
were sacrificed 3 days postexposure.   
 
LPS Treatment. 
 
      A solution of lipopolysaccharide (LPS) (Sigma Chemical Co., St. Louis, MO) in 
sterile water (0.5mg/Kg) was intraperitoneally injected to the rats. The rats were 
sacrificed 2 hours after LPS treatment. 
 
3.2 Bronchoalveolar Lavage (BAL) and Determination of BAL Markers 
 
BAL.  
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      Rats were deeply anesthetized with an overdose of sodium pentobarbital (200 mg/kg, 
ip; Butler, Columbus, OH) and euthanized by exsanguination via the vena cava. After 
clamping off the right apical lobe, the trachea was cannulated and the remaining lung 
lobes were first lavaged with 6 ml Ca2+/Mg2+-free phosphate buffered solution (PBS, 145 
mM NaCl, 5 mM KCl, 1.9 mM NaH2PO4, 9.35 mM Na2HPO4, and 5.5 mM glucose; pH 
7.4). The first BAL fluid sample was centrifuged at 500 × g for 10 min at 4°C, and the 
resultant cell-free supernatant (~ 4 ml/rat) was analyzed for various biochemical 
parameters. The lungs were further lavaged with 6 ml aliquots of PBS until 80 ml of BAL 
fluid was collected. These samples were also centrifuged for 10 min at 500 × g, and the 
cell-free BAL fluid discarded. The cell pellets from all washes for each rat were 
combined, washed, and resuspended in PBS and evaluated as described below.    
 
BAL Cell Differentiation.   
  
      The BAL cells were numerated couted using a CoulterMultisizer II and AccuComp 
software (Coulter Electronics, Hialeah, FL). Cell suspensions (5 × 104 cells) were 
centrifuged for 5 min at 800 rpm and pelleted onto a slide using a Cytospin centrifuge 
(Shandon Life Sciences International, Cheshire, England). Three hundred cells per rat 
were identified and differentiated after labeling with Leukostat stain (Fisher Scientific, 
Pittsburgh, PA). The absolute numbers of cells differentiated were calculated by 
multiplying the total number of cells by the percentage of the total within each cell type. 
 
Albumin and LDH.    
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      The albumin content, which indicates injury to the bronchoalveolar-capillary barrier, 
and LDH activity, which indicates cytotoxicity, were determined in the first fraction of 
acellular BAL fluid, using a COBAS MIRA auto-analyzer (Roche Diagnostic Systems, 
Montclair, NJ). Albumin content was determined colorimetrically at 628 nm based on 
albumin binding to bromcresol green using an albumin BCG diagnostic kit (Sigma). 
Lactate dehydrogenase activity was determined by measuring the oxidation of lactate to 
pyruvate coupled with the formation of reduced form of nicotinamide adenine 
dinucleotide at 340 nm using the Roche Diagnostic reagents and procedures (Roche 
Diagnostic Systems, Indianapolis, IN). 
 
Chemiluminescence (CL).   
 
      The light generation as CL by resting or stimulated AM as a result of ROS production 
was determined in a total volume of 0.5 ml HEPES buffer. Resting CL was determined 
by incubating BAL cells containing 0.5 × 106 AM at 37°C for 10 min in 0.008 % (w/v) 
luminol (Sigma) followed by the measurement of CL for 15 min. Luminol was used as an 
amplifier to enhance detection of the light and was first dissolved in a small amount of 
ethanol before being brought up to its final concentration in HEPES buffer. To determine 
zymosan-stimulated CL, unopsonized zymosan (2 mg/ml, Sigma) was added immediately 
prior to the measurement of CL. Measurement of CL was performed with an automated 
Berthold Autolumat LB 953 luminometer (Wallace, Inc., Gaithersburg, MD) for 15 min, 
and the integral of counts versus time was calculated. Zymosan-stimulated CL was 
calculated as the total counts of stimulated cells minus the total counts of the 
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corresponding resting cells. The zymosan-stimulated CL was attributed to AM only, as 
rat neutrophils do not respond to unopsonized zymosan in this system. 
 
NO Production.   
 
      The production of NO by AM was determined as follows. Cells were suspended in 
Eagle’s minimum essential medium (MEM, Biowhittaker, Walkersville, MD) 
supplemented with 1 mM glutamine, 100 µg/ml streptomycin, 100 units/ml penicillin, 
and 10% heat-inactivated fetal bovine serum (FBS). Aliquots of 1 ml cell suspension 
containing 2 × 106 AM were incubated in a humidified incubator (37°C and 5% CO2) for 
2 h to allow cell attachment to the culture plate. The non-adherent BAL cells were 
removed by rinsing the monolayer three times with culture medium. The remaining AM-
enriched cells were incubated in 1 ml medium for 24 h at 37°C and 5% CO2. The level of 
nitrite produced from NO in the AM-conditioned media was measured colorimetrically 
with the Greiss reaction using sodium nitrite as a standard (Green et al., 1982). The levels 
of NO in the first fraction of acellular BAL fluids were also determined using the Greiss 
assay. 
 
Western Blot Analysis.   
 
      The recovered AM-enriched cells were washed with PBS and then suspended in 100 
µl of a lysis buffer (50 mM Tris-HCl, 1% NP-40, 2 mM EDTA, 100 mM NaCl, 20 µg/ml 
aprotinin, 20 µg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride; pH 7.5) and left on 
ice for 10 min. Cytoplasmic extracts were separated from the nuclei by centrifugation at 
14,000 rpm for 10 min at 4°C,  and protein content determined using a BCA Protein 
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Assay Kit (Pierce, Rockford, IL). An equal amount of protein (30 µg / well) for each 
sample was boiled for 5 min, loaded, and run for electrophoresis in a 4-20% Tris-Glycine 
gel (Invitrogen, Carlsbad, CA) at 125 V. The gel was transferred electrophoretically (Bio-
Rad Laboratories, Hercules, CA) to a nitrocellulose membrane (Schleicher & Schuell, 
Keene, NH), and the blots were blocked with 5% milk in TBST buffer (20 mM Tris-HCl, 
100 mM NaCl, 0.1% Tween 20; pH 7.5) for 1 h at room temperature. Membranes were 
then probed with a polyclonal rabbit antibody against inducible NO synthase (iNOS) and 
a horseradish peroxidase-conjugated anti-rabbit IgG (Santa Cruz Biotechnology, Santa 
Cruz, CA). Blots were developed using commercially developed enhanced 
chemiluminescence reagent (Amersham Biosciences, Piscataway, NJ). For quantification, 
bands in photographs were scanned by a densitometer linked to a computer system 
(Personal Densitometer SI, Amersham Biosciences, Piscataway, NJ). 
 
3.3 Analysis of Lymphocytes from Lung-Draining Lymph Nodes (LDLN) 
 
Isolation of Lymphocytes.   
 
      Lymphocytes were isolated from LDLN as described previously (Yin et al., 2003). 
Briefly, LDLN were excised from each rat after BAL, teased apart, and homogenized 
with a glass pestle in a screen cup (Sigma). Single cell suspensions were obtained by 
passing the cell clumps through a 22-gauge needle attached to a 10-ml syringe, and 
washed twice with PBS.  Lymphocytes were isolated by Histopaque (density 1.083; 
Sigma) gradient centrifugation. Samples were centrifuged for 30 min at 2500 rpm, and 
lymphocytes were collected, washed, re-suspended in 1 ml of PBS, and counted using a 
standard hemocytometer. The cell samples thus prepared showed predominance of 
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lymphocytes and cell viability of greater than 98% as determined by the trypan blue 
exclusion technique. 
 
Flow Cytometric Analysis.   
 
      The effects of OVA and/or DEP exposures on frequencies of T cell subsets in LDLN, 
i.e., the expression of CD3, CD4, and CD8 cell surface markers, were examined with a 
flow cytometric method described elsewhere (Yin et al., 2003). Lymphocytes (106 cells) 
were stained with the addition of FITC-labeled conjugated antibodies against these cell 
surface markers (BD Pharmingen, San Diego, CA). The flow cytometric data were 
collected with a Becton-Dickinson FACScan using FACScan Research Software 
(Becton-Dickinson Immunocytometry System) and analyzed using the PC-LYSYS 
software (Becton-Dickinson). 
 
3.4 Cytokine Production.  
 
      The BAL cells were suspended in Eagle’s minimum essential medium (MEM, 
Biowhittaker, Walkersville, MD) supplemented with 1 mM glutamine, 100 µg/ml 
streptomycin, 100 units/ml penicillin, and 10% heat-inactivated fetal bovine serum. 
Aliquots of 1 ml cell suspensions, adjusted to contain 2×106 AM, were added to each 
well of a 24-well tissue culture plate and incubated in a humidified incubator (37°C and 
5% CO2) for 2 h to allow cell attachment to the culture plate. The nonadherent BAL cells 
were then removed by rinsing the monolayer three times with culture medium. The 
remaining AM-enriched cells or lymphocytes (2 × 106) isolated from LDLN were then 
incubated in 1 ml medium at 37°C and 5% CO2 for 24 h. The AM- or lymphocyte-
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conditioned media were collected, centrifuged (1200 × g for 4 min), and aliquots of the 
supernatants were stored at -70°C until assayed. 
 
      The production of IL-10 in AM-conditioned media under various exposure conditions 
was quantified by the enzyme-linked immunosorbent assay (ELISA) using the OptEIA 
ELISA Sets (BD PharMingen) as previously described (Yin et al., 2004a). The levels of 
IL-12 in the AM-conditioned media and IL-4 and interferon (IFN)- γ in the lymphocyte-
conditioned media and serum were quantified by ELISA using commercial ELISA kits 
(BioSource International, Inc., Camarillo, CA). The range of detection was: 7.8–500 
pg/ml for IL-4 and IL-12, 15.6–1000 pg/ml for IL-10, and 31.3–2000 pg/ml for IFN-γ. 
 
      The levels of IL-10, IL-6, and IL-1β in blood samples from saline, DEP (by i.t) and 
LPS (by i.p) treated rats were measured by ELISA using commercial ELISA kits 
(BioSource International, Inc., Camarillo, CA).  
 
3.5 Determination of Intracellular GSH 
  
      Alveolar macrophages or lymphocytes (2×105 cells) were plated in 96-well 
microplates, washed twice with PBS, and lysed with 240 µl of a cold lysing buffer (0.1% 
triton X-100 in 0.1 M sodium phosphate buffer, 5 mM EDTA, pH 7.5). The lysates were 
acidified with 0.1 N HCl (12 µl) and protein precipitated with 50% sulfosalicyclic acid 
(12 µl) followed by centrifugation at 4°C. Samples of the supernatants were assayed for 
total GSH according to the method of Buchmuller-Rouiller et al. (1995). Briefly, 50 µl of 
cell supernatants or GSH standards were distributed to each well of a 96-well microplate, 
followed by 50 µl of 2.4 mM 5,5'-dithio-bis(2-nitrobenzoic acid). After the mixture was 
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incubated at room temperature for 10 min, 50 µl each of NADPH (0.667 mg/ml) and 
glutathione reductase (40µg/ml) were added. The results of the GSH-specific reaction 
were monitored by OD readings at 405 nm every minute for 8 min with a Spectramax 
250 plate spectrophotometer using Softmax Pro 2.6 software (Molecular Devices Corp., 
Sunnyvale, CA). One of the OD readings obtained with the most satisfied standard curve 
was selected as the final result. 
 
3.6 Determination of OVA-Specific IgE and IgG from Blood Serum 
 
      Blood samples were collected during exsanguination from the vena cava of rats at 
sacrifice. The sera dilutions with 5% horse serum albumin (HOSA)/PBS of 1/50 were 
analyzed for OVA-specific IgE and IgG. Diluted sera (100 µl) were added to a 96-well 
plate (ICN Biomedicals, Horsham, PA) that had been previously coated with 200 µl of 
1% OVA carbonate coating buffer and blocked with a 5% HOSA/coating buffer 
according to the method of Voller and Bidwell (1986). The plates were incubated 
overnight at 4°C and subsequently incubated with sheep anti-rat IgE (100 µl, 1:2500 
dilution in HOSA/PBS, ICN Biomedicals, Costa Mesa, CA) which, according to 
manufacturer provided information, is specific for IgE class and does not cross-react with 
the other Ig classes, including IgG. The plates were then incubated with horseradish 
peroxidase-bound donkey anti-sheep IgG (100 µl, 1:5000 dilution in HOSA/ PBS, ICN 
Biomedicals) for 2 h each at room temperature. The plates were washed 3 times after 
each incubation, treated with tetramethylbenzidine (Sigma), and read at 630 nm. 
Ovalbumin-specific IgG was determined using goat anti-rat IgG (1:500 dilution in 
HOSA/PBS, Sigma) and peroxidase-labeled rabbit anti-goat IgG (1:12,500 dilution in 
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HOSA/PBS, Sigma) as detection antibodies, following the same protocol described 
above. The serum from one animal exposed to OVA was assigned a value of 100 and 
used as a reference to obtain relative concentrations for the OVA-specific IgE and IgG in 
serum samples from each group. 
 
3.7 Analysis of Alveolar Type II (ATII) Cells 
 
 Isolation of ATII Cells.   
 
      Type II cells were isolated using a standard protocol (Dobbs et al., 1986). Briefly, 
after removal of AM and blood cells, elastase solution (MP Biomedicals, Inc., Irvine, 
CA) was instilled via the trachea to dissociate the cells from lung tissue. The lung tissue 
was then minced in the presence of DNase I (Sigma) and FBS, and the suspension was 
sequentially filtered through nylon mesh. The cell suspension was plated on 
bacteriological plastic dishes coated with rat IgG (Sigma). After 1 h at 37°C, the 
nonadherent ATII cells were removed from the plate to which AM and other immune 
cells were adherent. Cells obtained by this method contained ~ 90% ATII cells and >90% 
excluded trypan blue. 
 
 Western Blot Analysis.   
 
      Expression of iNOS in ATII cells was determined by Western blot analysis using the 
same procedures for AM as described above, using cytoplasmic protein (30 µg/well) 
extracted from the freshly isolated ATII cells. 
 
Flow Cytometric Analysis for ROS   
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      Freshly isolated ATII cells (5 × 105 cells) were washed with a washing buffer (PBS 
with 2% FBS and 0.02% NaN3, pH 7.4), and re-suspended in DMEM/F12 medium 
(Invitrogen, Carlsbad, CA) containing 10 µM of 4,5 diaminofluorescein diacetate (DAF, 
Sigma) or 5 µM dihydroethidium (DHE, Molecular Probes, Eugene, OR) at 37°C for 30 
min. After washing, the flow cytometric data were immediately collected with a Becton-
Dickinson FACScan using FACScan Research Software (Becton-Dickinson 
Immunocytometry System, San Jose, CA), and analyzed using the PC-LYSYS software 
(Becton-Dickinson).  
 
3.8 Measurement of Airway Responsiveness  
 
      Airway responsiveness was assessed by inducing airflow obstruction with a 
methacholine (MCh) aerosol using a noninvasive method (Hamelmann et al., 1997). 
Minute volume, tidal volume, breathing frequency, and enhanced pause (Penh) were 
obtained from conscious rats placed in a whole-body plethysmograph (Buxco Electronics 
Inc., Troy, NY). In this system, rats were unrestrained and tolerated repetitive 
measurements. Measurements of MCh responsiveness were obtained by exposing rats for 
3 min to aerosolized PBS and incremental doses (6.25-25 mg/ml) of aerosolized MCh 
(Sigma) in PBS, and monitoring the breathing pattern for 3 min after each MCh 
challenge. The Penh values measured during each 3-min sequence were averaged and 
expressed, for each MCh concentration, as a percentage of baseline Penh values observed 
after PBS exposure. 
 
3.9 Analysis of B Lymphocytes from Spleens.  
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Isolation of B Lymphocytes. 
 
      B lymphocytes from rats that had been treated with DEP and saline by i.t. were 
isolated from the spleen according to the manufacturer’s protocol as described in the 
commercial MagCellect rat B cell isolation kit (R & D Systems, MN). Cells were 
cultured in 96 - well round-bottomed microtiter culture plates in PRMI 1640 
supplemented with 10% fetal calf serum, 2 mmol/L glutamine, 50 U/ml penicillin, and 50 
µg/ml streptomycin. B cells were seeded at 2 x 105 cells in 0.2 ml complete PRMI per 
well cocultured with OVA (10mg/ml), IL-4 (10ng/ml) and LPS (10 µg/ml). Cultures were 
maintained at 37°C in a 5% atmosphere for 7, 14, 21days, at each time point the 
supernatant was collected for IgE measurement. 
 
Determination of OVA- specific IgE.  
 
      IgE production by B lymphocytes was measured by the same analysis using the same 
procedures as for blood which were described above.  
 
3.10 Immunohistochemistry 
 
      Before BAL, the right apical lobe was clamped off to prevent entry of lavage fluid. 
Following BAL and excision of LDLN, the clamp was removed and all lobes were 
inflated intratracheally with 10% formalin. The right apical lobe was processed within 24 
h and embedded in paraffin. Sections were cut at 5 µm, deparaffinized in xylene, 
rehydrated, and stained for iNOS expression (Porter et al., 2002). Briefly, microwave 
antigen retrieval with citrate buffer (pH 6.0) of rehydrated tissue was performed, 
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followed by peroxidase blocking with a 1:1 mixture of 3% H2O2 and methanol. Slides 
were incubated overnight at 4°C with iNOS monoclonal antibody (N32020, Transduction 
Laboratories, Lexington, KY, 1:50 dilution). Localization was achieved using a 
streptavidin-biotinperoxidase system for use on rat specimens (K0609, Dako, Carpinteria, 
CA), with diaminobenzidene (Zymed Laboratories, San Francisco, CA) as the 
chromogen. Tissues were counterstained with Mayer’s hematoxylin, dehydrated and 
covered with a coverslip. Non-stained sections where the primary antibody was omitted 
were obtained as negative controls, and sections from rats that had been intratracheally 
instilled with lipopolysacchride (LPS, Sigma, 10mg/kg) 24 h prior to sacrifice were 
stained for positive controls. 
 
3.11 Statistical Analysis 
 
      Results are expressed as means ± standard error (SE). The significance of the 
interaction among different treatment groups for different parameters at each time point 
was assessed by analysis of variance (ANOVA). The significance of difference between 
individual groups was analyzed using the Tukey-Kramer’s Honestly Significant Different 
Test. For all analyses, the criterion of significance was set at p < 0.05. 
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4. RESULTS 
 
4.1 Results for Protocol A 
 
Lung Inflammation/Injury 
 
      The LDH activity and albumin content in the first acellular BAL fluids of rats from 
various exposure groups were determined as markers of lung injury and cytotoxicity 
(Figure 1), whereas the numbers of recovered AM, Polymorphonuclear neutrophils 
(PMNs), lymphocytes, and eosinophils in BAL fluids were counted as an index of airway 
inflammation (Figure 2).  These data show that both the BAL proteins and inflammatory 
cell counts for DEP exposure alone, when measured at 9 and 30 days after exposure, 
were not different from those of the air-exposed control, suggesting that DEP exposure 
did not cause lung injury at 9 or 30 days post-exposure.  Exposure of rats to OVA 
(administered weekly at a dose of 40.5 ± 6.3 mg/m3) caused significant increases in 
neutrophils, lymphocytes, eosinophils, albumin, and LDH activity in the rat lung after 
two exposures (measured at day 9).  These increases were further substantiated in rats 
receiving 5 OVA exposures (measured at day 30), with a clear increase in total BAL cells 
apparent when comparing to that of the air-exposed control.  DEP exposure alone did not 
induce inflammation but had a strong effect on OVA-induced inflammatory responses.  
As shown in Figures 1 and 2, the combined DEP and OVA exposure resulted in a 
significant decrease in OVA-induced inflammatory cell infiltration at day 30 and LDH 
and albumin at days 9 and 30 of DEP exposure.   
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Alveolar Macrophage Function 
 
      NO, an important marker of allergic inflammatory responses, in the acellular BAL 
fluid (Figure 3) and in AM-conditioned media (Figure 4) from various exposure groups 
was determined.  The OVA exposure resulted in an increase in NO levels in the acellular 
BAL fluid and AM-conditioned media.  This increase, however, was significantly 
attenuated in rats already exposed to DEP.  DEP exposure alone did not affect NO 
production in samples obtained at day 9, although the NO levels in the BAL fluid at day 
30 showed a moderate decrease comparing to that of the air-exposed controls.  
 
      Figure 5 shows the production of IL-10 and IL-12 by AM.  DEP exposure had no 
significant effect on the production of IL-10 (Figure 5A) or IL-12 (Figure 5B) by AM 
recovered from rats 9 and 30 days after exposure. In contrast, OVA sensitization 
markedly elevated both IL-10 and IL-12 secretion by AM at both time points. The 
production of these cytokines by AM from rats exposed to both DEP and OVA was 
significantly lower than cells from rats exposed to OVA alone.   
 
Lymphocyte Population and Cytokine Production 
 
       Figure 6 shows the numbers of lymphocytes, T cells, and their CD4+ and CD8+ 
subsets recovered from LDLN for each exposure group on day 9 (Figure 6A) and day 30 
(Figure 6B).  DEP exposure was found to increase the numbers of total lymphocytes, T 
cells, and their CD4+ and CD8+ subsets in the LDLN compared to the air-exposed 
control. Likewise, OVA exposure significantly increased these cell counts on day 9 as 
well as on day 30.  In the combined DEP and OVA exposure, however, there was a 
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significant reduction in total lymphocytes, T cells and CD4+ and CD8+ subsets in the rat 
lung on day 30 when compared to data for the OVA-only exposure groups.  
       
      Levels of IL-4 and IFN-γ in lymphocyte-conditioned media were below the detection 
limit of the ELISA kits used. The effects of DEP and OVA exposure on these cytokines, 
therefore, could not be determined. 
 
Intracellular GSH Levels in AM and Lymphocytes 
 
      The effect of DEP and OVA exposures on intracellular GSH levels was studied in 
AM (Figure 7A) and lymphocytes (Figure 7B) from various exposure groups.  DEP 
exposure alone slightly decreased GSH levels in AM, but markedly reduced GSH 
concentration in lymphocytes on day 9 and day 30. Exposure to OVA significantly 
decreased intracellular GSH in both cell types. Under the combined DEP and OVA 
exposure, AM and lymphocytes exhibited a greater depletion of intracellular GSH at day 
9 and at day 30 compared to either DEP or OVA exposure alone. 
 
OVA-Specific IgE and IgG Levels in Serum 
 
      In all samples collected on day 9, both serum IgE and IgG levels were under the 
detection limits. On day 30, neither air- nor DEP-exposed rats exhibit measurable IgE 
levels in the serum (Figure 8A).  The OVA exposure, however, resulted in elevated IgE 
level, and this antibody production was further enhanced in rats pre-exposed to DEP 
(Figure 8A). The IgE level for the combined DEP and OVA exposure was 2.2-times 
higher than that of the OVA exposure alone. Similarly, OVA sensitization also increased 
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OVA-specific IgG production, and in combination with DEP exposure, resulted in an 
even greater production of IgG (Figure 8B). The IgG level for the combined DEP and 
OVA exposure was about 2-times higher than that of the OVA exposure alone. These 
results indicate that DEP have an adjuvant effect on the production of both IgG and IgE. 
 
Effects of DEP and OVA on Lung iNOS Expression  
 
      Immunohistochemical analysis of iNOS in lung tissues showed that AM from various 
exposure groups did not stain for iNOS.  At day 9 after DEP exposure, one of the five rats 
in the combined DEP and OVA exposure showed slightly positive iNOS staining in the 
airway epithelium. On day 30, two of the 5 rats from the combined exposure and one of 
five rats from the OVA exposure alone showed positive airway staining.  In comparison, 
both AM and airway epithelia from LPS-treated animals were highly positive in iNOS 
staining (data not shown).  
 
4.2 Results for Protocol B 
 
Lung Inflammation/Injury  
 
      The LDH activity and albumin content in the first fraction of acellular BAL fluid 
(Figure 9) and the numbers of AM, eosinophils, neutrophils, and lymphocytes recovered 
from BAL fluid (Figure 10) were determined as measurements of lung injury and airway 
inflammation. None of DEP, OVA, or the combined OVA and DEP exposure induced 
elevated levels of LDH activity and albumin content, indicating that the exposure 
protocols did not cause significant lung injury that may complicate the experimental 
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results. DEP exposure alone induced a moderate but significant increase in the number of 
neutrophils recovered from BAL fluid. OVA exposure induced a greater infiltration of 
neutrophils than DEP, and also resulted in infiltration of eosinophils and lymphocytes.  
The OVA-induced eosinophil count was markedly increased by DEP, even though DEP 
exposure alone had no effect on this cell type. In comparison, the OVA-mediated 
infiltration of neutrophils and lymphocytes was not augmented by DEP in the combined 
OVA-DEP exposure. These results show that DEP, under the current dose and exposure 
protocol, did not cause substantial inflammation to the lung or augment OVA- induced 
neutrophil and lymphocyte infiltration, but strongly enhanced the infiltration of 
eosinophils that mediates airway inflammation and AHR.   
 
Lymphocyte Population  
 
      The numbers of total lymphocytes, T cells, and their CD4+ and CD8+ subsets in 
LDLN from rats sensitized and challenged by OVA were significantly higher than those 
of the air-exposed, non-sensitized rats (Figure 11).  While DEP exposure alone 
moderately increased these lymphocyte counts, the combined DEP and OVA exposure 
resulted in a substantial increase in the numbers of CD4+ and CD8+ T cells compared to 
cell counts measured for OVA exposure alone.  
 
ROS and NO Production  
 
      AM from various exposure groups were assessed for ROS production by 
measurement of CL in response to zymosan stimulation (Figure 12). Exposure to DEP or 
OVA alone had no effect on CL production by AM. However, a substantial elevation in 
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CL was observed for the combined OVA and DEP exposure group. The production of 
NO, a highly reactive nitrogen intermediate, was measured in the acellular BAL fluid 
(Figure 13) and in AM-conditioned media (Figure 14).   Both OVA and DEP exposures 
resulted in increased presence of NO in the acellular BAL fluid and in AM-conditioned 
media, and these levels were further increased in samples from the combined OVA and 
DEP exposure.  
 
      The effect of DEP exposure on OVA-induced generation of nitrogen species and 
reactive oxygen was also studied in ATII cells isolated from the rats. The intracellular 
presence of NO (Figure 15) and superoxide (Figure 16) were determined by flow 
cytometry after the cells were stained with DAF-DA and DHE, the relative specific 
probes for intracellular generation of NO and superoxide, respectively. The ATII cells 
from OVA-exposed rats exhibited higher percentage of cells that produce NO and 
superoxide than those of the air-exposed, non-sensitized rats. While DEP exposure alone 
increased the percentage of ATII cells that produce superoxide but not NO, the combined 
DEP and OVA exposure resulted in significant increase in the percentage of the cells that 
produce NO (Figure 15) and superoxide (Figure 16) over the control.  
 
GSH Levels in AM and Lymphocytes  
 
      The levels of GSH in AM and lymphocytes from DEP or OVA-exposed rats were not 
significantly changed compared to the controls (Figure 17). Under combined DEP and 
OVA exposure, however, the intracellular GSH levels were significantly reduced in both 
cell types compared to all other groups.    
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OVA-specific IgE and IgG Production  
 
      In all the samples collected from non-sensitized rats, both IgE and IgG concentrations 
were under the detection limits.  OVA sensitization resulted in a significant production of 
antigen-specific IgE, and its level was 2-times higher in rats that received the combined 
OVA and DEP exposure than in rats sensitized to OVA but exposed to air (Figure 18A). 
OVA sensitization also resulted in the production of OVA-specific IgG, whose level was 
likewise increased, 1.7 fold, by DEP exposure (Figure 18B). DEP exposure alone had no 
effect on IgG production.  These results indicate that DEP exposure augments the 
immune responses of rats to OVA in the production of allergen-specific IgE and IgG.  
 
Airway Reactivity  
 
      The effect of DEP exposure on OVA-induced AHR was evaluated from Penh values 
in rats from various treatment groups following MCh challenge (Figure 19). The baseline 
Penh values were not significantly affected by OVA or DEP.  However, airway 
responsiveness to MCh was significantly increased in rats from the combined OVA and 
DEP, whereas it was not in rats from other exposure groups. Thus, DEP exposure had a 
synergistic effect with OVA on inducing AHR in rats.   
 
iNOS Expression  
 
      Immunohistochemical analysis for iNOS expression in lung tissues showed no 
staining of AM in any exposure group. However, the airway epithelium was found 
positive in all five rats from the combined DEP and OVA exposure, 3 out of 5 rats from 
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DEP or OVA exposure alone, and 2 out of 5 rats from the air-exposed, non-sensitized 
control (data not shown). The OVA exposure was also found to increase iNOS expression 
in AM and ATII cells isolated from the rats as detected by Western blot analysis (Figure 
20). Although DEP exposure alone did not induce iNOS in AM and ATII cells, the 
combined DEP and OVA exposure resulted in a significantly higher iNOS expression in 
these cells than those from any other groups. 
 
4.3 Results of Effects of DEP on B Lymphocytes and Cytokine Production 
 
OVA-specific IgE Production  
 
      OVA-specific Ig E production by B lymphocytes isolated from saline, DEP, and LPS 
exposed rats showed no difference on day7, day14 and day21 (figure 21).  
 
Cytokine Production 
 
      IL-1β and IL-10 production in blood serum showed no difference between different 
treatment groups (figure 22 + 23). However, LPS exposure resulted in a great increase in 
the IL-6 production in blood samples compared with that from saline and DEP treated 
rats (figure 24). 
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Figure 1.  Yield of (A) LDH activity and (B) albumin content in bronchoalveolar lavage 
(BAL) fluid from rats (n = 5). *Significantly different from air + saline group, p < 0.05; 
+Significantly different from air + OVA group, p < 0.05. 
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Figure 2.   Total numbers and differentials of BAL cells recovered at (A) day 9 and (B) 
day 30 post-DEP exposure (n = 5). *Significantly different from air + saline group, p < 
0.05; +Significantly different from air + OVA group, p < 0.05. AM: alveolar 
macrophages, PMN: polymorphonuclear neutrophils, LYM: lymphocytes, EOS: 
eosinophils. 
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Figure 3. Concentrations of NO in BAL fluid. *Significantly different from air + saline 
group, p < 0.05; +Significantly different from air + OVA group, p < 0.05. 
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Figure 4.  Concentrations of NO in AM-conditioned media (n = 5). *Significantly 
different from air + saline group, p < 0.05; +Significantly different from air + OVA 
group, p < 0.05. 
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 Figure 5.  Production of (A) IL-10 and (B) IL-12 by AM. AM were incubated at 37°C 
and 5% CO2 for 24 h. Concentrations of the cytokines in the culture media were 
quantified (n = 5). *Significantly different from air + saline group, p < 0.05; 
+Significantly different from air + OVA group, p < 0.05. 
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Figure 6. Lymphocyte differentiation in lung-draining lymph nodes (LDLN) of rats at 
(A) day 9 and (B) day 30 post-DEP exposure (n = 5). *Significantly different from air + 
saline group, p < 0.05; +Significantly different from air + OVA group, p < 0.05. 
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Figure 7. Concentrations of intracellular GSH in (A) AM and (B) lymphocytes isolated 
from lung-draining lymph nodes of rats at day 9 and day 30 post-DEP exposure (n = 5). 
*Significantly different from air + saline group, p < 0.05; +Significantly different from air 
+ OVA group, p < 0.05. 
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Figure 8.  Relative concentrations of OVA-specific (A) IgE and (B) IgG in serum 
collected at day 30 post-DEP exposure (n = 5). +Significantly different from air + OVA 
group, p < 0.05. UD: Under detection limit. 
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Figure 9. LDH activity (A) and albumin content (B) in the first fraction of BAL fluid 
collected from rats. Values are expressed as the means ± SE (n = 5). No significant 
difference was found among any treatments for both measurements. 
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Figure 10. Differentials of BAL cells recovered from rats. Values are expressed as the 
means ± SE  (n = 5). *Significantly different from air + saline group, p < 0.05; 
+Significantly different from air + OVA group, p < 0.05. 
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Figure 11. Numbers and differentials of lymphocytes isolated from lung-draining lymph 
nodes (LDLN) of rats. Values are expressed as the means ± SE  (n = 5). *Significantly 
different from air + saline group, p < 0.05; +Significantly different from air + OVA 
group, p < 0.05. 
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Figure 12. Zymosan-stimulated CL by AM. Values are expressed as the means ± SE  (n 
= 5). *Significantly different from air + saline group, p < 0.05; +Significantly different 
from air + OVA group, p < 0.05. 
 
 
 
 
 
 75 
 
 
N
itr
ite
 
in
 
BA
L 
flu
id
 
(µ M
)
0
5
10
15
20
25
Saline + air
Saline + DEP
OVA + air
OVA + DEP
* *
*
+
Figure 13. Nitrite in BAL fluid. Values are expressed as the means ± SE  (n = 5). 
*Significantly different from air + saline group, p < 0.05; +Significantly different from air 
+ OVA group, p < 0.05. 
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Figure 14. Nitrite in AM-conditioned media. Values are expressed as the means ± SE  (n 
= 5). *Significantly different from air + saline group, p < 0.05; +Significantly different 
from air + OVA group, p < 0.05. 
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Figure 15.  Flow cytometric analysis of intracellular generation of NO by ATII cells. 
Values are expressed as the means ± SE  (n = 5). *Significantly different from air + saline 
group, p < 0.05; +Significantly different from air + OVA group, p < 0.05. 
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Figure 16. Flow cytometric analysis of intracellular generation of superoxide by ATII 
cells. Values are expressed as the means ± SE  (n = 5). *Significantly different from air + 
saline group, p < 0.05; +Significantly different from air + OVA group, p < 0.05. 
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Figure 17. Concentration of intracellular GSH in AM (A) and lymphocytes (B) isolated 
from lung-draining lymph nodes of rats. Values are expressed as the means ± SE  (n = 5). 
*Significantly different from air + saline group, p < 0.05; +Significantly different from air 
+ OVA group, p < 0.05. 
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Figure 18.  Relative concentrations of OVA-specific IgE (A) and IgG (B) in serum 
collected from rats. Values are expressed as the means ± SE (n = 5). +Significantly 
different from air + OVA group, p < 0.05. UD: under detection limit. 
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Figure 19.  Airway hyperresponsiveness in rats 24 h after OVA challenge. 
Responsiveness was assessed by measuring enhanced pause (Penh) values of rats in 
response to inhaled methacholine (Mch) aerosolized from MCh solutions in PBS at 
various concentrations (6.25-25 mg/ml). Values are expressed as the means ± SE  (n = 5) 
of the percentage of baseline Penh values after PBS exposure. *Significantly different 
from air + saline group, p < 0.05; +Significantly different from air + OVA group, p < 
0.05. 
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Figure 20. Western blot analysis of iNOS expression in AM (A) and ATII cells (B). The 
top panels show representive results of the Western blot analysis and the bottom panels 
show percentage increase in band density which represents the means ± SE (n = 5). 
*Significantly different from air + saline group, p < 0.05; +Significantly different from air 
+ OVA group, p < 0.05. 
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Figure 21. Relative concentrations of OVA-specific IgE in B cells isolated from spleens 
of saline, DEP and LPS treated rats. Values are expressed as the means ± SE (n = 4).  
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Figure 22.  Production of IL-1β in serum in different exposure groups. BN rats were 
exposed to saline, DEP by i.t. and LPS by i.p.. Values are expressed as the means ± SE (n 
= 4). 
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Figure 23.  Production of IL-10 in serum in different exposure groups. BN rats were 
exposed to saline, DEP by i.t. and LPS by i.p.. Values are expressed as the means ± SE (n 
= 4). 
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Figure 24.  Production of IL-6 in serum in different exposure groups. BN rats were 
exposed to saline, DEP by i.t. and LPS by i.p.. Values are expressed as the means ± SE (n 
= 4). *Significantly different from saline group, p < 0.05. 
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5. DISCUSSION 
 
       Experimental models of asthma, as in BN rats, require a sensitization period for the 
animal to develop the allergic response. Diesel exhaust particle exposure, on the other 
hand, is known to induce acute inflammatory responses through particle stimulation but 
anti-inflammatory responses through the organic component of DEP (Yin et al., 2004b; 
Ma and Ma, 2002). Hence, the effects of DEP on allergic responses may vary depending 
on the sensitization process and the timing of DEP exposure. In practical settings, 
subjects may be sensitized or nonsensitized to an allergen and may encounter DEP and 
allergen exposure at different time points, thus making the timing of DEP exposure an 
important factor for assessment of allergic responses. The present study was designed to 
characterize the effect of short-term DEP exposure on OVA-mediated airway responses 
and mechanism of DEP exposure on altering OVA induced airway inflammation and 
antigen-specific IgE and IgG production under two exposure protocols using an OVA-
allergic rat model. The dose for DEP exposure (22.7 ± 2.5 mg/m3) appears to be high in 
comparison to the reported environmental and occupational concentrations, but in fact it 
results in a lung deposition (402 ± 58 µg/rat) that is relevant to both non-occupational and 
occupational exposure settings as discussed previously (Yin et al., 2002, 2004a). The 
results showed that in both protocols, the inhaled DEP enhanced the sensitization of rats 
to OVA in antigen-specific antibody production. This result, together with that from 
previous studies, suggests that frequent exposure to DEP may alter allergy-related 
responses in both previously sensitized and nonsensitized individuals, thus contributing 
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to the manifestations and increased prevalence of asthma (Lovik et al., 1997; Diaz-
Sanchez et al., 1994, 1997; Takano et al., 1997). 
 
       DEP are carbon-based particles containing various organic compounds adsorbed onto 
the carbonaceous core. The organic component-mediated reactive oxygen species (ROS) 
generation plays an important role in cell-mediated immune responses (Yin et al., 2004b; 
Ma and Ma, 2002; Whitekus et al., 2002). The imbalance between cellular antioxidants 
and ROS levels can lead to oxidative stress and a depletion of intracellular thiol levels. 
Increasing clinical, epidemiological, and experimental evidence indicates that excess 
production of ROS and defective endogenous antioxidant defense mechanisms are 
associated with asthma (Henricks and Nijkamp, 2001). Glutathione-S-transferases 
(GSTs), for example, have been shown to be key regulators of the adjuvant effects of 
DEP on allergic responses. Compared with patients with a functional genotype, 
individuals with GSTM1 null or the GSTP1 I105 wild type genotypes showed enhanced 
nasal allergic responses in the presence of DEP, including increased production of 
antigen-specific IgE (Gilliland et al., 2004). As an important immune modulator, 
intracellular GSH has a regulatory role in antigen presenting cells, including AM, 
dendritic cells, and B cells, which is critical for the development of T cell-mediated 
immunity and the predominance of cellular production of Th1 or Th2 cytokines (Peterson 
et al., 1998; Ma and Ma, 2002; Murata et al., 2002).  Our studies in protocol A showed 
that DEP exposure alone markedly reduced the levels of GSH in lymphocytes and, to a 
lesser extend, in AM at 9 and 30 days post DEP exposure, and that the combined DEP 
and OVA exposure resulted in a synergistic depletion of GSH in both cell types. 
However, the OVA-induced CD4+ T cells and AM secretion of IL-10 and IL-12 were 
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significantly decreased by DEP, while two other cytokines (IL-4 and IFN-γ) were not 
successfully detected. The fact that DEP aggravate intracellular GSH depletion in AM 
and lymphocytes suggests that the organic component of DEP, which induces 
intracellular ROS (Yin et al., 2004b), may play a role in the elevation of antigen-specific 
IgE and IgG. Although a clear switch of T-cell immunity toward Th2 response in terms 
of cytokine profile cannot be concluded from this study, elevated levels of OVA-specific 
IgE and IgG in the DEP plus OVA group strongly suggest the occurrence of this switch 
in vivo. 
 
       In protocol A we also showed that DEP exposure prior to OVA sensitization 
inhibited allergen-induced airway inflammation measured at 4 weeks post exposure. In 
agreement with this finding, we have previously shown that preexposure to DEP 
significantly decreased the number of inflammatory cells (AM and neutrophiles) in the 
lung and T cells and their CD4+ and CD8+ subsets in LDLN recovered from Listeria 
monocytogenes- infected BN rats (Yin et al., 2004a). Inhibition of OVA-induced airway 
inflammation by DEP as shown by the BAL cell differentials in this study, albeit not an 
unexpected effect, contrasted with that reported previously (Takano et al., 1998; 
Miyabara et al., 1998a; Sagai et al., 1996). This discrepancy suggests that DEP may have 
multiple effects on allergic responses, depending on the status of the lung inflammation 
induced by both allergens and particles. On one hand, DEP exhibit time-dependent 
effects on allergen-induced airway inflammatory responses by increasing allergic 
inflammation in already-sensitized individuals or during the sensitization process, but 
attenuating these responses induced by delayed sensitization in previously nonsensitized 
individuals. On the other hand, local inflammation induced by DEP (or other particles), 
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which is significant or not, depending on the doses and timing for exposure, is another 
important factor for DEP to affect allergen-related inflammation. In concurrent exposure 
studies, the aggravation of allergen-induced inflammatory responses by DEP, such as 
those reported by Takano et al. (1997, 1998), is expected, since the acute pulmonary 
responses to DEP exposure alone also involve inflammatory cell infiltration, airway 
inflammation, and altered lymphocyte function (Miyabara et al., 1998a; Sagai et al., 
1996; Takano et al., 1998). In protocol A, no significant acute inflammatory response or 
lung injury was expected, while we did not examine the acute pulmonary response of rats 
to DEP exposure. According to the same exposure dose and protocol, DEP alone did not 
induce significant acute inflammatory responses and lung injury in BN rats as shown by 
the previous results (Yin et al., 2004a). 
 
      The mechanism through which inhaled DEP inhibit the allergen-induced airway 
inflammation in protocol A is complex but may involve a number of factors including 
NO, ROS, and their effects on cellular cytokine production. Studies in rats and mice have 
shown that NO production from lung cells (epithelial cells, macrophages, and Th1 cells) 
may down-regulate Th1 cell-derived IFN-γ production and concomitantly up-regulate 
local expression of Th2 cell-derived IL-4 and IL-5 (Barnes and Liew, 1995), thus 
promoting the development of pulmonary eosinophilia and airway hyperreactivity (Liu et 
al., 1997; Feder et al., 1997). Although immunohistochemical analysis of lung tissues 
failed to detect alterations in iNOS expression in AM, the current study in protocol A 
showed that inhaled DEP significantly inhibit OVA-induced NO production in AM-
conditioned media and BAL fluid, and this corresponds to an attenuation of OVA 
induced eosinophilia. It has been known that DEP, through the organic compounds, 
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induce cellular expression of antioxidative enzymes that contribute to the anti-
inflammatory responses. One such enzyme is heme oxygenase-1 (HO-1). We have shown 
previously that DEP up-regulated expression of HO-1 in AM through a mechanism that 
involves the organic component-induced CYP1A1 and ROS generation (Rengasamy et 
al., 2003; Yin et al., 2004b). Studies have shown that HO-1 may act through carbon 
monoxide, a major catalytic byproduct of HO-1-mediated heme degradation, which, 
interestingly, has also been shown to reduce allergen induced airway 
hyperresponsiveness and eosinophilia (Chapman et al., 2001). Additionally, studies in 
animal models of allergic asthma showed that CD8-deficent mice or those with depleted 
CD4+T cells developed significantly lowered airway hyperresponsiveness and 
eosinophilic inflammation, indicating an important role of these T-cell subsets in airway 
eosinophilia (Miyahara et al., 2004b; Gavett et al., 1994; Komai et al., 2003). The 
inhibition of OVA-induced CD4+ and CD8+ T lymphocytes by DEP exposure, as 
demonstrated in our study, thus may also contribute to its attenuation of allergic airway 
inflammation.  
 
       AM play a pivotal role in controlling and directing immune responses by secreting a 
variety of mediators including both pro-inflammatory and anti-inflammatory cytokines. 
We and others have shown previously that in vivo or in vitro exposure to DEP suppressed 
AM phagocytotic capacity and their secretion of pro-inflammatory cytokines, such as IL-
1β, IL-12, and TNF-α, in response to bacterial infection or LPS stimulation (Amakawa et 
al., 2003; Saito et al., 2002; Yin et al., 2002). These studies indicated that DEP exposure 
dampened AM function and responses to external stimuli and that DEP may play a role in 
reducing inflammation. Indeed, DEP, at low dose were shown to exert an anti-
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inflammatory effect on bacteria-induced lung inflammation in rats (Yin et al., 2004a). 
Consistent with these results, the current study  in protocol A showed that DEP 
significantly suppressed AM secretion of NO, IL-10, and IL-12 in response to OVA 
stimulation. In view of the decreased lung inflammation in the combined DEP- and 
OVA-exposed rats, the observed reduction in OVA-induced IL-10 by DEP seems 
puzzling, since lines of evidence have led to the hypothesis that IL-10 may act as one of 
the anti-inflammatory cytokines that regulate ongoing inflammatory responses (de Vries, 
1995). In fact, the regulatory role of endogenous IL-10 in asthma remains unclear. 
Previous studies have reported that IL-10 production in response to LPS was impaired in 
the monocyte/macrophage cell lineage of asthmatics (Borish et al., 1996; John et al., 
1998), whereas other studies have reported an increase of IL-10-producing T cells and 
macrophages in asthmatic airways and a further increase of those cells after an allergen 
challenge (Colavita et al., 2000; Magnan et al., 1998; Robinson et al., 1996). 
Furthermore, experimental asthma studies using IL-10 knockout mice have provided 
controversial results in which increased or decreased airway inflammatory responses to 
allergen challenge were found (Justice et al., 2001; Makela et al., 2000; Yang et al., 
2000). Interestingly, the IL-10 knockout mice showed increased or no changeable Th2 
responses including allergen-specific IgE production (Justice et al., 2001; Yang et al., 
2000). These results, together with that obtained from the current study, show that the 
role of IL-10 in regulating allergen-related airway inflammatory responses may be very 
complex and need to be further studied. On the other hand, one would speculate on a 
decreased IgE production in the DEP-plus-OVA exposure group because AM antigen 
presenting function may be also dampened. Since AM are poor antigen-presenting cells 
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compared to dendritic cells (Nicod et al., 2000), inhibition of AM function by DEP may 
not significantly affect the antigen presenting in the lung and subsequent antibody 
production. Inhibition of AM function by DEP may be, at least in part, responsible for the 
decreased production of both Th1 and Th2 cytokines as examined in the DEP plus OVA 
exposed rats. 
 
       In protocol B, exposure of non-sensitized rats to DEP resulted in only a moderate 
increase in neutrophils in the lung, and there was a clear absence of eosinophilic 
inflammation, antibody responses, or AHR. However, in OVA-sensitized rats, pre-
exposure to DEP markedly enhanced OVA-induced AHR, eosinophils infiltration, and 
serum OVA-specific IgE and IgG production. Although alterations in the lung cytokine 
profile were unknown, the results show that DEP pre-exposure strongly enhances the 
OVA-induced Th2 responses in antibody production as well as eosinophil-mediated 
airway inflammation. To our knowledge, this is the first demonstration of a DEP 
enhanced allergic AHR in rats. These results are consistent with, and complement those 
obtained using various mouse models where DEP exposure was co-administered with 
antigen challenge (Ichinose et al., 1997, 2002; Miyabara et al., 1998b; Takano et al., 
1997, 1998). It is interesting to point out that we demonstrated that DEP exposure prior to 
the sensitization enhanced the sensitization in antibody production but inhibited airway 
inflammation induced by OVA challenge using the same rat model (protocol A). Thus, 
the action of DEP exposure on allergic asthma is such that it affects both the sensitization 
and the asthmatic response of animals to the allergen. 
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       The mechanisms through which DEP alter the allergic reactions remain unclear in 
part because of the complex, time-dependent effects of DEP on allergen-induced immune 
responses. One of the cellular actions of DEP is the induction of intracellular ROS 
through the organic component-mediated activation of cytochrome P450 1A1 and other 
metabolic enzymes (Ma and Ma, 2002; Whitekus et al., 2002; Yin et al., 2004b). The 
imbalance of cellular antioxidative responses to ROS generation induced by DEP leads to 
oxidative stress and a reduction of total intracellular GSH in AM and lymphocytes (Al-
Humadi et al., 2002c). In protocol B we show that ROS generation in AM and ATII cells 
is an important feature of the combined DEP and OVA exposure. As shown by CL 
measurements, a marked increase in oxidant activity, which corresponds to a lowered 
total GSH concentration in AM and lymphocytes, is associated with the combined DEP 
and OVA exposure, which is greater than either DEP or OVA exposure alone. This 
suggests that DEP preexposure augments ROS production by cells from OVA sensitized 
rats. GSH, in addition to its role in protecting cells from oxidative injury, is critical to 
macrophages and dendritic cells that act as antigen-presenting cells for the development 
of T-cell–mediated immune responses. Depletion of GSH in these cells has been shown 
to skew the development of T cells from Th1 to Th2 type (Murata et al., 2002; Peterson 
et al., 1998), a manifestation of increased allergic asthmatic responses. That DEP 
augment OVA-specific antibody production is consistent with the fact that DEP facilitate 
depletion of GSH in AM and lymphocytes. 
 
       Nitric oxide has been considered an important marker in allergen-induced 
inflammatory responses. This reactive nitrogen intermediate can directly react with and 
deplete intracellular GSH (Folkes and Wardman, 2004) and may play a role in the 
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development of eosinophilia and AHR in mouse and rat allergic models (Feder et al., 
1997; Liu et al., 1997). It has been shown that NO derived from iNOS in epithelial cells 
promotes asthmatic inflammation by downregulating Th1 cells that secrete interferon-γ 
and concomitantly upregulate Th2 cells that secrete IL-4 and IL-5 (Barnes and Liew, 
1995). On the other hand, the constitutive NO-synthase (cNOS)–derived NO has been 
shown to exert bronchoprotective effects in asthma including airway smooth muscle 
relaxation and inhibition of smooth muscle proliferation (Ricciardolo et al., 2001, 2003). 
In fact, NO derived from cNOS and from iNOS may play different roles in the airways. 
The former seems to protect airways from excessive bronchoconstriction while the latter 
has a modulatory role in inflammatory disorders of the airways such as asthma. The 
effect of DEP pre-exposure, as shown in protocol B, is to increase iNOS expression in 
AM and ATII cells of OVA sensitized and challenged rats, suggesting that DEP interact 
directly with these lung cells. This interaction results in an acute response of increased 
production of NO that is known to mediate OVA-induced eosinophilic inflammation and 
AHR. 
 
       Our study shows an apparent linkage between the ROS and NO generation with 
increased responses of T lymphocytes. Both DEP and OVA exposure in protocol B 
enhanced the numbers of T cells and their CD4+ and CD8+ subsets recovered from the 
LDLN in the BN rat model. But it was the combined DEP and OVA exposure that 
yielded a substantial increase in T cell responses, which correlate with increased 
production of ROS and NO and decreased level of GSH. Clinical investigations have 
observed that CD4+ T lymphocytes and their secretion of Th2 cytokines played a central 
role in initiating and sustaining asthmatic responses in the asthmatic airway (Robinson, 
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2000). Studies in animal models further showed that depletion of CD4+ T lymphocytes by 
administration of anti-CD4 antibody inhibited allergen-induced airway eosinophilia and 
AHR (Gavett et al., 1994; Komai et al., 2003). CD8+ T lymphocytes also play a role in 
allergic responses. Miyahara et al. (2004a, b) showed that CD8-deficient mice had a 
significantly lower AHR and eosinophilia in response to OVA sensitization and challenge 
comparing to the wild-type, but the allergic response was fully restored by adoptive 
transfer of antigen-primed effector CD8+ T cells. 
 
       Pulmonary type II cells are the principal cell type that expresses P450 and NOS 
enzymes in the lung. The allergic asthma is associated with increased protein nitration 
and airway inflammation due to the induction of iNOS in epithelial cells (Trifilieff et al, 
2000; Iijima et al, 2001), suggesting that alteration of type II cell enzyme expression by 
DEP may be responsible for the adjuvant effect of DEP on airway inflammation in 
sensitized rats. To gain more insight, the effects of DEP and OVA on enzume expressions 
and cellular production of reactive oxygen and nitrogen species were determined in 
protocol B. Rats were sensitized with aerosolized OVA and exposed to DEP following 
protocol B, sacrificed on Day 31, and analyzed for type II cell expression of CYP 
enzymes and iNOS. Western blot analysis showed that OVA exposure alone induced 
iNOS expression and slightly down-regulated CYP2B1. DEP exposure alone induced 
CYP 1A1 but not iNOS expression. In combined exposure, however, DEP significantly 
augmented the induction of iNOS by OVA. Flow cytometric analysis further showed that 
DEP exposure alone increased the percentage of cells that produce superoxide but not 
NO comparing to the control, OVA exposure alone moderately enhanced the percentage 
of cells with increased NO and superoxide, but the combined exposure resulted in 
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significant increase in the percentage of cells that produce NO, superoxide, and 
peroxynitrite over either OVA or DEP exposure alone. These results show a positive 
involvement of type II cells in the production of reactive oxygen and nitrogen species, 
and suggest that this cell type is a target by DEP and OVA in the induction of airway 
inflammation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 98 
6. REFERENCES 
 
Adonis, M., Martinez, V., Riquelme, R., Ancic, P., Gonzalez, G., Tapia, R., Castro, M., 
Lucas, D., Berthou, F., Gil, L. (2003). Susceptibility and exposure biomarkers in people 
exposed to PAHs from diesel exhaust. Toxicol Lett. 144, 3-15. 
 
Al-Humadi, N.H., Ma, J.K.H., Lewis, D.M., Ma, J.Y.C., Barger, M.W., Siegel, P.D. 
(2002a). Dose-dependent thiol and immune responses to ovalbumin challenge in Brown 
Norway rats. Toxicol Ind Health. 18, 343-52. 
 
Al-Humadi, N.H., Siegel, P.D., Lewis, D.M., Barger, M.W., Ma, J. Y. C., Weissman, 
D.N., Ma, J.K.H. (2002b). The effect of diesel exhaust particles (DEP) and carbon 
black (CB) on thiol changes in pulmonary ovalbumin allergic sensitized Brown Norway 
rats. Exp Lung Res. 28, 333-49. 
 
Al-Humadi, N. H., Siegel, P. D., Lewis, D. M., Barger, M. W., Ma, J. Y. C., Weissman, 
D. N., and Ma, J. K. H. (2002c). Alteration of intracellular cysteine and glutathione 
levels in alveolar macrophages and lymphocytes by diesel exhaust particle exposure. 
Environ. Health Perspect. 110, 349–353. 
 
Akerboom, T.P, Bilzer, M., Sies, H. (1982). The relationship of biliary glutathione 
disulfide efflux and intracellular glutathione disulfide content in perfused rat liver. J 
Biol Chem. 257, 4248-52. 
 
Amakawa, K., Terashima, T., Matsuzaki, T., Matsumaru, A., Sagai, M., and Yamaguchi, 
K. (2003). Suppressive effects of diesel exhaust particles on cytokine release from 
human and murine alveolar macrophages. Exp. Lung Res. 29, 149–164. 
 
Arlt, V.M., Bieler, C.A., Mier, W., Wiessler, M., Schmeiser, H.H. (2001). DNA adduct 
formation by the ubiquitous environmental contaminant 3-nitrobenzanthrone in rats 
determined by (32)P-postlabeling. Int J Cancer. 93, 450-4. 
 
Aruoma, O.I., Halliwell, B., Dizdaroglu, M. (1989). Iron ion-dependent modification of 
bases in DNA by the superoxide radical-generating system hypoxanthine/xanthine 
oxidase. J Biol Chem. 264, 13024-8. 
 
Attfield, M.D., Trabant, G.D., Wheeler, R.W. (1982). Exposure to diesel fumes and dust 
at six potash mines. Ann Occup Hyg. 26, 817-31. 
 
Azzawi, M., Bradley, B., Jeffery, P. K. et al. (1990). Identification of activated T 
lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. 
Respir. Dis. 142 , 1407–13. 
 
 99 
Baeza-Squiban, A., Bonvallot, V., Boland, S., Marano, F. (1999). Airborne particles 
evoke an inflammatory response in human airway epithelium. Activation of 
transcription factors. Cell Biol Toxicol. 15, 375-80 
 
Barnes, P. J., and  Liew, F. W. (1995). Nitric oxide and asthmatic inflammation. 
Immunol Today 128, 128–130. 
Baulig, A., Garlatti, M., Bonvallot, V., Marchand, A., Barouki, R., Marano, F., Baeza-
Squiban, A. (2003). Involvement of reactive oxygen species in the metabolic pathways 
triggered by diesel exhaust particles in human airway epithelial cells. Am J Physiol 
Lung Cell Mol Physiol. 285, L671-9. 
Bayram, H., Devalia, J.L., Sapsford, R.J., Ohtoshi, T., Miyabara, Y., Sagai, M., Davies, 
R.J. (1998a). The effect of diesel exhaust particles on cell function and release of 
inflammatory mediators from human bronchial epithelial cells in vitro. Am J Respir 
Cell Mol Biol. 18, 441-8. 
Bayram, H., Devalia, J.L., Khair, O.A., Abdelaziz, M.M., Sapsford, R.J., Sagai, M., 
Davies, R.J. (1998b). Comparison of ciliary activity and inflammatory mediator release 
from bronchial epithelial cells of nonatopic nonasthmatic subjects and atopic asthmatic 
patients and the effect of diesel exhaust particles in vitro. J Allergy Clin Immunol. 102, 
771-82. 
Beck, S., Soukup, J.M., Gilmour. M.I., Devlin, R.B. (1996). Stimulation of human and rat 
alveolar macrophages by urban air particulates: effects on oxidant radical generation 
and cytokine production. Toxicol Appl Pharmacol. 141, 637-48. 
 
Bergdahl, I.A., Toren, K., Eriksson, K., Hedlund, U., Nilsson, T., Flodin, R., Jarvholm, 
B. (2004). Increased mortality in COPD among construction workers exposed to 
inorganic dust. Eur Respir J. 23, 402-6.  
 
Bhatia, R., Lopipero, P., Smith, A.H. (1998). Diesel exhaust exposure and lung cancer. 
Epidemiology. 9, 84–91.  
Bigert, C., Gustavsson, P., Hallqvist, J. ( 2003). Myocardial infarction among 
professional drivers. Epidemiology. 14, 333-339.  
Boland, S., Baeza-Squiban, A., Fournier, T., Houcine, O., Gendron, M.C., Chevrier, M., 
Jouvenot, G., Coste, A., Aubier, M., Marano, F. (1999). Diesel exhaust particles are 
taken up by human airway epithelial cells in vitro and alter cytokine production. Am J 
Physiol. 276, L604-13 
Bond, J.A., Johnson, N.F., Snipes, M.B., Mauderly, J.L. (1990). DNA adduct formation 
in rat alveolar type II cells: cells potentially at risk for inhaled diesel exhaust. Environ 
Mol Mutagen. 16, 64-9. 
Borm,  P.J., Driscoll, K. (1996). Particles, inflammation and respiratory tract 
carcinogenesis. Toxicol Lett. 88, 109-13. 
 100 
Borish, L., Aarons, A., Rumbyrt, J., Cvietusa, P., Negri, J., and Wenzel, S. (1996). 
Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. 
Immunol. 97, 1288–1296. 
Brauer, M., Hoek, G., Van Vliet, P., Meliefste, K., Fischer, P.H., Wijga, A., Koopman, 
L.P., Neijens, H.J., Gerritsen, J., Kerkhof, M., Heinrich, J., Bellander, T., Brunekreef, 
B. (2002). Air pollution from traffic and the development of respiratory infections and 
asthmatic and allergic symptoms in children. Am J Respir Crit Care Med.. 166, 1092-8. 
Brown, D. M., Donaldson, K., Borm, P. J., Schins, R. P., Dehnhardt, M., Gilmour, P.,  
Jimenez, L. A., and Stone, V. (2004). Calcium and ROSmediated activation of  
transcription factors and TNF-a cytokine gene expression in macrophages exposed to  
ultrafine particles. Am. J. Physiol. Lung Cell. Mol. Physiol. 286, L344–L353. 
 
Bruske-Hohlfeld, I., Mohner, M., Ahrens, W., Pohlabeln, H., Heinrich, J., Kreuzer, M., 
Jockel, K.H., Wichmann, H.E. (1999). Lung cancer risk in male workers occupationally 
exposed to diesel motor emissions in Germany. Am J Ind Med. 36, 405-14. 
Bruske-Hohlfeld, I., Mohner, M., Pohlabeln, H. (2000). Occupational lung cancer risk for 
men in Germany: results from a pooled case-control study. Am J Epidemiol.151, 384–
95.  
Bunn, W.B. 3rd, Hesterberg, T.W., Valberg, P.A., Slavin, T.J., Hart, G., Lapin, C.A. 
(2004). A reevaluation of the literature regarding the health assessment of diesel engine 
exhaust. Inhal Toxicol. 16, 889-900. 
Bunn, W.B. 3rd, Valberg. P.A., Slavin, T.J., Lapin, C.A. (2002). What is new in diesel. 
Int Arch Occup Environ Health. 75 Suppl, S122-32.  
Busse, W.W., Lemanske, R.F. Jr. (2001). Asthma. N Engl J Med. 344, 350-62. 
 
California EPA (1997). ‘‘Public and Scientific Review Draft. Health RiskAssessment for 
Diesel Exhaust.’’ Office of Environmental Health Hazard Assessment, California 
Environmental Protection Agency, Berkeley, March 1997. 
 
Chapman, J. T., Otterbein, L. E., Elias, J. A., and Choi, A. M. (2001). Carbon monoxide 
attenuates aeroallergen-induced inflammation in mice. Am. J. Physiol. Lung Cell. Mol. 
Physiol. 281, L209–L216. 
 
Colavita, A. M., Hastie, A. T., Musani, A. I., Pascual, R. M., Reinach, A. J., Lustine, H. 
T., Galati, S. A., Zangrilli, J. G., Fish, J. E., and Peters, S. P. (2000). Kinetics of IL-10 
production after egmental antigen challenge of atopic asthmatic subjects. J. Allergy 
Clin. Immunol. 106, 880–886.  
 
D'Amato, G. (1999). Outdoor air pollution in urban areas and allergic respiratory 
diseases. Monaldi Arch Chest Dis 54, 470-474. 
 101 
D'Amato, G., Liccardi, G., D'Amato, M. (1998). Environment and development of 
respiratory allergy: I. Outdoors. Monaldi Arch Chest Dis, 49, 406–411. 
 
DeLeve, L.D., Kaplowitz, N. (1990). Importance and regulation of hepatic glutathione. 
Semin Liver Dis. 10, 251-66. 
 
Devalia, J.L., Bayram, H., Rusznak, C., Calderon, M., Sapsford, R.J., Abdelaziz, M.A., 
Wang, J., Davies, R.J. (1997). Mechanisms of pollution-induced airway disease: in 
vitro studies in the upper and lower airways. Allergy. 52(38 Suppl), 45-51. 
 
de Vries, J. E. (1995). Immunosuppressive and anti-inflammatory properties of 
interleukin-10. Ann. Med. 27, 537–541. 
 
Diaz-Sanchez, D., Dotson, A. R., Takenaka, H., and Saxon, A. (1994). Diesel exhaust 
particles induce local IgE production in vivo and alter the pattern of IgE messenger 
RNA isoforms. J. Clin. Invest. 94, 1417–1425. 
 
Diaz-Sanchez, D., Garcia, M.P., Wang, M., Jyrala, M., Saxon, A. (1999). Nasal 
challenge with diesel exhaust particles can induce sensitization to a 
neoallergen in the human mucosa. J Allergy Clin Immunol. 104, 1183-8. 
 
Diaz-Sanchez, D., Tsien, A., Fleming, J., and Saxon, A. (1997). Combined diesel exhaust 
particles and ragweed allergen challenge markedly enhances in vivo nasal ragweed-
specific IgE and skew cytokine production to a T helper cell 2-type pattern. J. Immunol. 
158, 2406–2413. 
 
Diaz-Sanchez,  D. (1997). The role of diesel exhaust particles and their associated 
polyaromatic hydrocarbons in the induction of allergic airway disease. Allergy. 52, 52-
56. 
Diaz-Sanchez, D., Dotson, A.R., Takenaka, H., Saxon, A. (1994). Diesel exhaust 
particles induce local IgE production in vivo and alter the pattern of IgE messenger 
RNA isoforms. J Clin Invest. 94, 1417-25. 
Diaz-Sanchez ,D., Garcia, M.P., Wang, M., Jyrala, M., Saxon, A. (1999). Nasal challenge 
with diesel exhaust particles can induce sensitization to a neoallergen in the human 
mucosa. J Allergy Clin Immunol. 104, 1183-8.    
Diaz-Sanchez, D., Tsien, A., Casillas, A., Dotson, A.R., Saxon, A.( 1996). Enhanced 
nasal cytokine production in human beings after in vivo challenge with diesel exhaust 
particles. J Allergy Clin Immunol. 98, 114-23. 
Diaz-Sanchez, D., Tsien, A., Fleming, J., Saxon, A. (1997). Combined diesel exhaust 
particulate and ragweed allergen challenge markedly enhances human in vivo nasal 
ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J 
Immunol. 158, 2406-13.  
 102 
Dick, C. A. J., Brown, D. M., Donaldson, K., and Stone, V. (2003). The role of free  
radicals in the toxic and inflammatory effects of four different ultrafine particle types.  
Inhal. Toxicol. 15, 39–52. 
 
Dockery, D.W., Pope, C.A. (1994). Acute respiratory effects of particulate air pollution. 
Ann Rev Publ Health.15, 107–132. 
 
 
Don Porto Carero, A., Hoet, P.H., Verschaeve, L., Schoeters, G., Nemery, B. (2001). 
Genotoxic effects of carbon black particles, diesel exhaust particles, and urban air 
particulates and their extracts on a human alveolar epithelial cell line (A549) and a 
human monocytic cell line (THP-1). Environ Mol Mutagen. 37, 155-63. 
Draper, W. M. (1986). Quantitation of nitro and dinitropolycyclic aromatic hydrocarbons  
in diesel exhaust particulate matter. Chemosphere 15, 437–447. 
 
Duhme, H., Weiland, S.k., Leil, U., Lraemer, B., Schmid, M., Stender, M., Chambless, L. 
(1996). The association between self-reported symptoms of asthma and allergic rhinitis 
and self-reported traffic density on street of residence in adolescents. Epidemiology. 7, 
578-582. 
 
Durham, S. R., Lee, T. H., Cromwell, O., Shaw, R. J., Merrett, T. G., Merrett, J., Cooper,   
P., and Kay, A. B. (1984). Immunologic studies in allergen-induced late-phase   
asthmatic reactions. J. Allergy Clin. Immunol. 47, 49–60. 
 
Dybing, E., Lovdal, T., Hetland, R. B., Lovik, M., and Schwarze, P. E. (2004). 
Respiratory allergy adjuvant and inflammatory effects of urban ambient particles.   
Toxicology 198, 307–314. 
 
Feder, L. S., Stelts, D., Chapman, R. W., Manfra, D., Crawley, Y., Jones, H., Minnicozzi, 
M., Fernandez, X., Paster, T., Egan, R.W., et al. (1997). Role of nitric oxide on 
eosinophilic lung inflammation in allergic mice. Am. J. Respir. Cell Mol. Biol. 17, 436- 
442. 
 
Finkelstein, M.M., Verma, D.K., Sahai, D., Stefov, E. (2004). Ischemic heart disease 
mortality among heavy equipment operators. Am J Ind Med.,46, 16-22. 
 
Fleming, D.M., Charlton, J.R. (2001). The prevalence of asthma and heart disease in 
transport workers: a practice-based study. Br J Gen Pract. 51, 638-43. 
 
Folkes, L. K., and Wardman, P. (2004). Kinetics of the reaction between nitric oxide and 
glutathione: implications for thiol depletion in cells. Free Radic. Biol. Med. 37, 549–
556. 
 
Foreman, R.C., Mercer, P.F., Kroegel, C., Warner, J.A. (1999). Role of the eosinophil in 
protein oxidation in asthma: possible effects on proteinase/antiproteinase balance. Int 
Arch Allergy Immunol. 118, 183-6. 
 103 
 
Foster, P.S., Hogan, S.P., Matthaei, K.I., Young, I.G. (1997). Interleukin-4 and 
interleukin-5 as targets for the inhibition of eosinophilic inflammation and allergic 
airways hyperreactivity. Mem Inst Oswaldo Cruz. 92 Suppl 2:55-61. 
 
Gamble, J.F., Jones, W.G. (1983a). Respiratory effects of diesel exhaust in salt miners. 
Am Rev Respir Dis. 128, 389-94. 
Gamble, J., Jones, W., Hudak, J. (1983b). An epidemiological study of salt miners in 
diesel and nondiesel mines. Am J Ind Med. 4, 435-58. 
Gamble, J., Jones, W., Minshall, S. (1987a). Epidemiological-environmental study of 
diesel bus garage workers: chronic effects of diesel exhaust on the respiratory system. 
Environ Res. 44, 6-17. 
Gamble, J., Jones, W., Minshall, S. (1987b). Epidemiological-environmental study of 
diesel bus garage workers: acute effects of NO2 and respirable particulate on the 
respiratory system. Environ Res. 42, 201-14.  
 
Garshick, E., Laden, F., Hart, J.E., Rosner, B., Smith, T.J., Dockery, D.W., Speizer, F.E. 
(2004). Lung cancer in railroad workers exposed to diesel exhaust. Environ Health 
Perspect.112, 1539-43. 
 
Garshick, E., Laden, F., Hart, J.E., Smith, T.J., Rosner, B. (2006). Smoking imputation 
and lung cancer in railroad workers exposed to diesel exhaust. Am J Ind Med. 49,709-18. 
 
Garshick, E., Schenker, M.B., Munoz, A., Segal, M., Smith, T.J., Woskie, S.R., 
Hammond, S.K., Speizer, F.E. (1987). A case-control study of lung cancer and diesel 
exhaust exposure in railroad workers. Am Rev Respir Dis.135, 1242-8. 
Garshick, E., Schenker, M.B., Munoz, A., Segal, M., Smith, T.J., Woskie, S.R., 
Hammond, S.K., Speizer, F.E. (1988). A retrospective cohort study of lung cancer and 
diesel exhaust exposure in railroad workers. Am Rev Respir Dis. 137, 820-5.  
Gavett, S. H., Chen, X., Finkelman, F., andWills-Karp, M. (1994). Depletion of murine 
CD4þ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary 
eosinophilia. Am. J. Respir. Cell Mol. Biol. 10, 587–593. 
Gielen, M.H., van der Zee, S.C., van Wijnen, J.H., van Steen, C.J., Brunekreef, B. 
(1997). Acute effects of summer air pollution on respiratory health of asthmatic 
children. 
Am J Respir Crit Care Med. 155, 2105-8. 
Gilliland, F. D., Li, Y. F., Saxon, A., and Diaz-Sanchez, D. (2004). Effect of glutathione-
S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: 
Randomised, placebo-controlled crossover study. Lancet 363, 119–125. 
 
 104 
Graham, L. M. (2004). All I need is the air that I breath: Outdoor air quality and asthma.  
Paediatr. Respir. Rev. 5(Suppl. A), S59–S64. 
 
Granum, B., Gaarder, P. I., Groeng, E. C., Leikvold, R. B., Namork, E., and Lovik, M.   
(2001). Fine particles of widely different composition have an adjuvant effect on the   
production of allergen-specific antibodies. Toxicol. Lett. 115, 171–181. 
 
Gustavsson, P., Plato, N., Hallqvist, J. (2001).  A population-based case-referent study of 
myocardial infarction and occupational exposure to motor exhaust, other combustion 
products, organic solvents, lead, and dynamite. Epidemiology. 12, 222-228. 
 
Hamada, K., Goldsmith, C. A., Goldman, A., and Kobzik, L. (2000). Resistance of very   
young mice to inhaled allergen sensitization is overcome by coexposure to an air- 
pollutant aerosol. Am. J. Respir. Crit. Care Med. 161, 1285–1293. 
 
Hart, J.E., Laden, F., Schenker, M.B., Garshick, E. (2006). Chronic obstructive 
pulmonary disease mortality in diesel-exposed railroad workers. Environ Health 
Perspect. 114, 1013-7. 
 
Hashimoto, S. , Gon, Y., Takeshita, I., Matsumoto, K., Jibiki, I., Takizawa, H., Kudoh, 
S., Horie, T. (2000). Diesel exhaust particles activate p38 MAP kinase to produce 
interleukin 8 and RANTES by human bronchial epithelial cells and N-acetylcysteine 
attenuates p38 M. Am J Respir Crit Care Med. 161, 280-5. 
Heinrich, J., Hoelscher, B., Wjst, M., Ritz, B., Cyrys, J., Wichmann, H. (1999). 
Respiratory diseases and allergies in two polluted areas in East Germany. Environ 
Health Perspect, 107, 1-17.  
Hiltermann, T.J., Peters, E.A., Alberts, B., Kwikkers, K., Borggreven, P.A., Hiemstra. 
P.S., Dijkman, J.H., van Bree, L.A., Stolk, J. (1998). Ozone-induced airway 
hyperresponsiveness in patients with asthma: role of neutrophil-derived serine 
proteinases. Free Radic Biol Med. 24, 952-8.  
Hirano, S., Furuyama, A., Koike, E., Kobayashi, T. (2003). Oxidative-stress potency of 
organic extracts of diesel exhaust and urban fine particles in rat heart microvessel 
endothelial cells. Toxicology.,187(2-3):161-70. 
Hnizdo, E., Vallyathan, V. (2003). Chronic obstructive pulmonary disease due to 
occupational exposure to silica dust: a review of epidemiological and pathological 
evidence. Occup Environ Med. 60, 237-43. 
Hoek, G., Brunekreef, B., Goldbohm, S., Fischer, P., van den Brandt, P.A. (2002). 
Association between mortality and indicators of traffic-related air pollution in the 
Netherlands: a cohort study. Lancet. 360, 1203-1209.  
Holgate, S.T., Sandstrom, T., Frew, A.J., Stenfors, N., Nordenhall, C., Salvi, S., 
Blomberg, A., Helleday, R., Soderberg, M.. (2003). Health effects of acute exposure to 
 105 
air pollution. Part I: Healthy and asthmatic subjects exposed to diesel exhaust. Res Rep 
Health Eff Inst.. 112,1-30; discussion 51-67. 
Hulsmann, A.R., Raatgeep, H.R., den Hollander, J.C., Stijnen, T., Saxena, P.R., 
Kerrebijn, K.F., de Jongste, J.C. (1994). Am. J. Respir. Crit. Care Med. 149, 519-525. 
 
IARC, (1989). Diesel engine exhaust. IARC Monogr Eval Carcinog Risks Hum. 46,  p41. 
 
Ichinose, T., Takano, H., Miyabara, Y., Sadakano, K., Sagai, M., and Shibamoto, T. 
(2002). Enhancement of antigen-induced eosinophilic inflammation in the airways of 
mast-cell deficient mice by diesel exhaust particles. Toxicology 180, 293–301. 
 
Ichinose, T., Takano, H., Miyabara, Y., Yanagisawa, R., and Sagai, M. (1997). Murine 
strain differences in allergic airway inflammation and immunoglobulin production by a 
combination of antigen and diesel exhaust particles. Toxicology 122, 183–192. 
 
Ichinose, T., Yajima, Y., Nagashima, M., Takenoshita, S., Nagamachi, Y., Sagai, M. 
(1997). Lung carcinogenesis and formation of 8-hydroxy-deoxyguanosine in mice by 
diesel exhaust particles. Carcinogenesis. 18, 185-92. 
 
Iijima, H., Duguet, A., Eum, S.Y., Hamid, Q., Eidelman, D.H. (2001). Nitric oxide and 
protein nitration are eosinophil dependent in allergen-challenged mice. Am J Respir 
Crit Care Med. 163, 1233-40.  
 
Ishizaki, T., Koizumi, K., Ikemori, R., Ishiyama, Y., Kushibiki, E. (1987). Studies of 
prevalence of Japanese cedar pollinosis among the residents in a densely cultivated 
area. Ann Allergy. 58, 265-70. 
Iwai, K., Adachi, S., Takahashi, M., Moller, L., Udagawa, T., Mizuno. S., Sugawara, I. 
(2000). Early oxidative DNA damages and late development of lung cancer in diesel 
exhaust-exposed rats. Environ Res. 84, 255-64. 
 
Jany, B., Betz, R., Schreck, R. (1995). Activation of the transcription factor NF-kappa B 
in human tracheobronchial epithelial cells by inflammatory stimuli. Eur Respir J. 8, 
387-91. 
Jarvholm B, Silverman D. (2003). Lung cancer in heavy equipment operators and truck 
drivers with diesel exhaust exposure in the construction industry. Occup Environ Med. 
60, 516-20. 
 
John, M., Lim, S., Seybold, J., Jose, P., Robichaud, A., O’Connor, B., Barnes, P. J., and 
Chung, K. F. (1998). Inhaled corticosteroids increase interleukin-10 but reduce 
macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating 
factor, and interferon-gamma release from alveolar macrophages in asthma. Am. J. 
Respir. Crit. Care Med. 157, 256–262. 
 
 106 
Justice, J. P., Shibata, Y., Sur, S., Mustafa, J., Fan, M., and Van Scott, M. R. (2001). IL-
10 gene knockout attenuates allergen-induced airway hyperresponsiveness in C57BL/6 
mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L363–L368. 
 
Kasai, H., Crain, P.F., Kuchino, Y., Nishimura, S., Ootsuyama, A., Tanooka, H. (1986). 
Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen 
radicals and evidence for its repair. Carcinogenesis. 7, 1849-51. 
Kehrer, J.P. (2000). The Haber-Weiss reaction and mechanisms of toxicity. Toxicology. 
149, 43-50. 
 
Knudsen, L.E., Gaskell, M., Martin, E.A., Poole, J., Scheepers, P.T., Jensen, A., Autrup, 
H., Farmer, P.B. (2005). Genotoxic damage in mine workers exposed to diesel exhaust, 
and the effects of glutathione transferase genotypes. Mutat Res. 583, 120-32. 
 
Komai, M., Tanaka, H., Masuda, T., Nagao, K., Ishizaki, M., Sawada, M., and Nagai, H. 
(2003). Role of Th2 responses in the development of allergeninduced airway 
remodeling in a murine model of allergic asthma. Br. J. Pharmacol. 138, 912–920. 
 
Koren, H. S. (1995). Associations between criteria air pollutants and asthma. Environ.    
Health Perspect. 103(Suppl. 6), 235–242. 
 
Krishna, M.T., Madden, J., Teran. L.M., Biscione, G.L., Lau, L.C., Withers, N.J.,   
Sandstrom, T., Mudway, I., Kelly, F.J., Walls, A., Frew, A.J., Holgate, S.T. (1998). 
Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage 
fluid and bronchial mucosa of healthy subjects. Eur Respir J. 11, 1294-300. 
 
Kuusimaki, L., Peltonen, Y., Mutanen, P., Peltonen, K., Savela, K. (2004). Urinary 
hydroxy-metabolites of naphthalene, phenanthrene and pyrene as markers of exposure 
to diesel exhaust. Int Arch Occup Environ Health. 77, 23-30.  
Kyriakis, J.M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E.A., Ahmad, M.F., Avruch, 
J., Woodgett, J.R. (1994). The stress-activated protein kinase subfamily of c-Jun 
kinases. Nature. 369, 156-60. 
 
Laden, F., Hart, J.E., Eschenroeder, A., Smith, T.J., Garshick, E. (2006). Historical 
estimation of diesel exhaust exposure in a cohort study of U.S. railroad workers and 
lung cancer. Cancer Causes Control. 17, 911-9. 
 
Lambert, A. L., Dong,W., Winsett, D. W., Selgrade, M. K., and Gilmour, M. I. (1999).   
Residual oil fly ash exposure enhances allergic sensitization to house dust mite. 
Toxicol.   Appl. Pharmacol. 158, 269–277. 
 
 Langen, R.C., Korn, S.H., Wouters, E.F. (2003). ROS in the local and systemic 
pathogenesis of COPD. Free Radic Biol Med. 35, 226-35. 
 
 107 
Larkin, E.K., Smith, T.J., Stayner, L., Rosner, B., Speizer, F.E., Garshick, E. (2000). 
Diesel exhaust exposure and lung cancer: adjustment for the effect of smoking in a 
retrospective cohort study. Am J Ind Med. 38. 399-409. 
Le Tertre. A., Medina, S., Samoli, E., Forsberg, B., Michelozzi, P., Boumghar, A., Vonk, 
J.M., Bellini, A., Atkinson, R., Ayres, J.G., Sunyer, J., Schwartz, J., Katsouyanni. K. 
(2002). Short-term effects of particulate air pollution on cardiovascular diseases in 
eight European cities.J Epidemiol Community Health. 56, 773-9. 
Lezcano-Meza, D, Teran, L.M. (1999). Occupational asthma and interleukin-8. Clin Exp 
Allergy. 29, 1301-3. 
Liccardi, G., D'Amato, M., D'Amato, G. (1998). Asthma in pregnant patients: 
pathophysiology and management. Monaldi Arch Chest Dis.  53, 151-9. 
Li, N., Kim, S., Wang, M., Froines, J., Sioutas, C., Nel, A. (2002). Use of a stratified 
oxidative stress model to study the biological effects of ambient concentrated and diesel 
exhaust particulate matter. Inhal Toxicol. 14, 459-86. 
 Lipsett, M., Campleman, S. (1999). Occupational exposure to diesel exhaust and lung 
cancer: a meta-analysis. Am J Public Health. 89, 1009–17. 
Lipsett, M., Hurley, S., Ostro, B. (1997). Air pollution and emergency room visits for 
asthma in Santa Clara County, California. Environ Health Perspect. 105, 216-222.  
 
Liu, S. F., Haddad, E. B., Adcock, I., Salmon, M., Koto, H., Gilbey, T., Barnes, P. J., and 
Chung, K. F. (1997). Inducible nitric oxide synthase after sensitization and allergen 
challenge of Brown Norway rat lung. Br. J. Pharmacol. 121, 1241–1246. 
 
 Lovik, M., Hogseth, A. K., Gaarder, P. I., Hagemannn, R., and Eide, I. (1997). Diesel 
exhaust particles and carbon black have adjuvant activity on the local lymph node 
response and systemic IgE production to ovalbumin. Toxicology 121, 165–178.  
 
Ma, J. Y. C., and Ma, J. K. H. (2002). The dual effect of the particulate and organic 
components of diesel exhaust particles on the alteration of pulmonary 
immune/inflammatory responses and metabolic enzymes. Environ. Carcinog. Ecotox. 
Rev. C 20, 117–147. . 
 
Magnan, A., van Pee, D., Bongrand, P., and Vervloet, D. (1998). Alveolar macrophage 
interleukin (IL)-10 and IL-12 production in atopic asthma. Allergy 53, 1092–1095. 
 
Makela, M. J., Kanehiro, A., Borish, L., Dakhama, A., Loader, J., Joetham, A., Xing, Z., 
Jordana, M., Larsen, G. L., and Gelfand, E. W. (2000). IL-10 is necessary for the 
expression of airway hyperresponsiveness but not pulmonary inflammation after 
allergic sensitization. Proc. Natl. Acad. Sci. U.S.A. 97, 6007–6012. 
 108 
Mamessier, E., Nieves, A., Vervloet, D., Magnan, A. (2006). Diesel exhaust particles 
enhance T-cell activation in severe asthmatics. Allergy. 61,581-8. 
Marano, F., Boland, S., Bonvallot, V., Baulig, A., Baeza-Squiban, A. (2002). Human 
airway epithelial cells in culture for studying the molecular mechanisms of the 
inflammatory response triggered by diesel exhaust particles. Cell Biol Toxicol. 18, 315-
20.  
Martin, L.D., Krunkosky, T.M., Dye, J.A., Fischer, B.M., Jiang, N.F., Rochelle, L.G., 
Akley, N.J., Dreher, K.L., Adler, K.B. (1997). The role of reactive oxygen and nitrogen 
species in the response of airway epithelium to particulates. Environ Health Perspect. 
105, 1301-7.  
Mastrangelo, G., Clonfero, E., Pavanello, S., Fedeli, U., Fadda, E., Turato, A., Piccinni, 
S., Montagnani, R., Marcer, G. (2003). Exposure to diesel exhaust enhances total IgE in 
non-atopic dockers. Int Arch Occup Environ Health. 76, 63-8.  
Mauderly, J.L.( 1997). Relevance of particle-induced rat lung tumors for assessing lung 
carcinogenic hazard and human lung cancer risk. Environ Health Perspect. 105 Suppl 5, 
1337-46.  
 
Mauderly, J.L., Banas, D.A., Griffith, W.C., Hahn, F.F., Henderson, R.F., McClellan, 
R.O. (1996). Diesel exhaust is not a pulmonary carcinogen in CD-1 mice exposed 
under conditions carcinogenic to F344 rats. Fundam Appl Toxicol. 30, 233-42.  
 
Mauderly, J.L., Jones, R.K., Griffith, W.C., Henderson, R.F., McClellan, R.O. (1987).  
Diesel exhaust is a pulmonary carcinogen in rats exposed chronically by inhalation. 
Fundam Appl Toxicol. 9, 208-21.  
 
Mills, N.L., Tornqvist, H., Robinson, S.D., Gonzalez, M., Darnley, K., MacNee, W., 
Boon, N.A., Donaldson, K., Blomberg, A., Sandstrom, T., Newby, D.E. (2005). Diesel 
exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. 
Circulation. 112,3930-6. 
 
Miyabara, Y., Ichinose, T., Takano, H., Lim, H. B., and Sagai, M. (1998a). Effects of 
diesel exhaust on allergic airway inflammation in mice. J. Allergy Clin. Immunol. 102, 
805–812. 
 
Miyabara, Y., Takano, H., Ichinose, T., Lim, H. B., and Sagai, M. (1998b). Diesel 
exhaust enhances allergic airway inflammation and hyperresponsiveness in mice. Am. 
J. Respir. Crit. Care Med. 157, 1138–1144. 
 
Miyahara, N., Swanson, B. J., Takeda, K., Taube, C., Miyahara, S., Kodama, T., 
Dakhama, A., Ott, V. L., and Gelfand, E. W. (2004a). Effector CD8+ T cells mediate 
inflammation and airway hyperresponsiveness. Nat. Med. 10, 865–869. 
 
 109 
Miyahara, N., Takeda, K., Kodama, T., Joetham, A., Taube, C., Park, J. W., Miyahara, S., 
Balhorn, A., Dakhama, A., and Gelfand, E. W. (2004b). Contribution of antigen-primed 
CD8+ T cells to the development of airway hyperresponsiveness and inflammation is 
associated with IL-13. J. Immunol. 172, 2549–2558. 
 
Monks, T.J., Hanzlik, R.P., Cohen, G.M., Ross, D., Graham, D.G. (1992). Quinone 
chemistry and toxicity. Toxicol Appl Pharmacol. 112, 2-16.  
Morrow, P.E., Haseman, J.K., Hobbs, C.H., Driscoll, K.E., Vu, V., Oberdorster, G. 
(1996). The maximum tolerated dose for inhalation bioassays: toxicity vs overload. 
Fundam Appl Toxicol. 29, 155-67. 
 
Murata, Y., Shimamura, T., and Hamuro, J. (2002). The polarization of T(h)1/T(h)2 
balance is dependent on the intracellular thiol redox status of macrophages due to the 
distinctive cytokine production. Int. Immunol. 14, 201–212.  
 
Muzyka, V.,  Bogovski, S., Scheepers, P., Volf, J., Kusova, J. (2003). Effects of 
occupational exposure to diesel exhaust on porphyrin metabolism in lymphocytes of 
workers employed at black coal and oil-shale mines. Am J Ind Med. 44, 70-4. 
 
Muzyka, V., Bogovski, S., Viitak, A., Veidebaum, T. (2002). Alterations of heme 
metabolism in lymphocytes and metal content in blood plasma as markers of diesel 
fuels effects on human organism. Sci Total Environ. 286, 73-81. 
Muzyka, V., Scheepers, P.T., Bogovski, S., Lang, I., Schmidt, N., Ryazanov, V., 
Veidebaum, T. (2004). Porphyrin metabolism in lymphocytes of miners exposed to 
diesel exhaust at oil shale mine. Sci Total Environ. 322, 41-50. 
 
Nel, A. E., Diaz-Sanchez, D., Ng, D., Hiura T., and Saxon, A. (1998). Enhancement of 
allergic inflammation by the interaction between diesel exhaust particles and the 
immune system. J. Allergy Clin. Immunol. 102, 539-54. 
 
Ng, D., Kokot, N., Hiura, T., Faris, M., Saxon, A., Nel, A. (1998). Macrophage activation 
by polycyclic aromatic hydrocarbons: evidence for the involvement of stress-activated 
protein kinases, activator protein-1, and antioxidant response elements. J Immunol. 161, 
942-51. 
Nicod, L. P., Cochand, L., and Dreher, D. (2000). Antigen presentation in the lung: 
Dendritic cells and macrophages. Sarcoidosis Vasc. Diffuse Lung Dis. 17, 246–255. 
Nikula, K.J., Snipes, M.B., Barr, E.B., Griffith, W.C., Henderson, R.F., Mauderly, J.L. 
(1995). Comparative pulmonary toxicities and carcinogenicities of chronically inhaled 
diesel exhaust and carbon black in F344 rats. Fundam Appl Toxicol. 25, 80-94. 
Nightingale, J.A., Maggs, R., Cullinan, P., Donnelly, L.E., Rogers, D.F., Kinnersley, R., 
Chung, K.F., Barnes, P.J., Ashmore, M., Newman-Taylor, A. (2000). Airway 
 110 
inflammation after controlled exposure to diesel exhaust particulates. Am J Respir Crit 
Care Med. 162, 161-6. 
NIOSH (1988). Current Intelligence Bulletin No. 50. Carcinogenic Effects of Exposure to 
Diesel Exhaust. Publication No. 88–116. National Institute of Occupational Safety and 
Health, U.S. Department of Health and Human Services. 
Nordenhall, C., Pourazar, J., Blomberg, A., Levin, J.O., Sandstrom, T., Adelroth, E. 
(2000). Airway inflammation following exposure to diesel exhaust: a study of time 
kinetics using induced sputum. Eur Respir J. 15, 1046-51.  
Nordenhall, C., Pourazar, J., Ledin, M.C., Levin, J.O., Sandstrom, T., Adelroth, E. 
(2001). Diesel exhaust enhances airway responsiveness in asthmatic subjects. Eur 
Respir J. 17, 909-15. 
Norris, G., YoungPong, S.N., Koenig, J.Q., Larson, T.V., Sheppard, L., Stout, J.W. 
(1999).  An association between fine particles and asthma emergency department visits 
for children in Seattle. Environ Health Perspect. 107, 489-493 
 
Oberdorster, G. (1995). Lung particle overload: implications for occupational exposures 
to particles. Regul Toxicol Pharmacol. 21, 123-35. 
Oberdorster, G. (1997). Pulmonary carcinogenicity of inhaled particles and the maximum 
tolerated dose. Environ Health Perspect. 105 Suppl 5, 1347-55.  
 
Ohta, K., Yamashita, N., Tajima, M., Miyasaka, T., Nakano, J., Nakajima, M., Ishii, A., 
Horiuchi, T., Mano, K., Miyamoto, T. (1999). Diesel exhaust particulate induces 
airway hyperresponsiveness in a murine model: essential role of GM-CSF. J Allergy 
Clin Immunol. 104, 1024-30.  
 
Oliver LC, Miracle-McMahill H, Littman AB, Oakes JM, Gaita RR Jr. (2001). 
Respiratory symptoms and lung function in workers in heavy and highway 
construction: a cross-sectional study. Am J Ind Med. 40, 73-86. 
 
Ordonez, C.L., Shaughnessy, T.E., Matthay, M.A., Fahy, J.V. (2000). Increased 
neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: 
Clinical and biologic significance. Am J Respir Crit Care Med. 161, 1185-90. 
Ormstad, H., Gaarder, P. I., Johansen, B. V., and Lovik, M. (1998). Airborne house dust   
elicits a local lymph node reaction and has an adjuvant effect on specific IgE 
production   in the mouse. Toxicology 129, 227–236. 
 
Owen, S., Pearson, D., Suarez-Mendez, V., O'Driscoll, R., Woodcock ,A. (1991). 
Evidence of free-radical activity in asthma. N Engl J Med. 325, 586-7. 
 
 111 
Pandya, R.J., Solomon, G., Kinner, A., Balmes, J.R. (2002). Diesel exhaust and asthma: 
hypotheses and molecular mechanisms of action. Environ Health Perspect. 110 Suppl 1, 
103-12.  
Parent, M.E., Rousseau, M.C., Boffetta, P., Cohen, A., Siemiatycki, J. (2006). Exposure 
to diesel and gasoline engine emissions and the risk of lung cancer. Am J Epidemiol. 
[Epub ahead of print] 
Pekkanen, J., Peters, A., Hoek, G., Tiittanen, P., Brunekreef, B., de Hartog, J., Heinrich, 
J., Ibald-Mulli, A., Kreyling, W.G., Lanki, T., Timonen, K.L., Vanninen, E. (2002). 
Particulate air pollution and risk of ST-segment depression during repeated submaximal 
exercise tests among subjects with coronary heart disease: the Exposure and Risk 
Assessment for Fine and Ultrafine Particles in Ambient Air (ULTRA) study. 
Circulation. 106, 933-8. 
Penning, T.M., Burczynski, M.E., Hung, C.F., McCoull, K.D., Palackal, N.T., Tsuruda, 
L.S. (1999). Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon 
activation: generation of reactive and redox active o-quinones. Chem Res Toxicol. 12, 
1-18.  
Peters, A., Dockery, D.W., Muller, J.E., Mittleman, M.A. (2001) Increased particulate air 
pollution and the triggering of myocardial infarction. Circulation. 103, 2810-5.  
Peters, A., Perz, S., Doring, A., Stieber, J., Koenig, W., Wichmann, H.E. (1999). 
Increases in heart rate during an air pollution episode. Am J Epidemiol. 150, 1094-8. 
Peters, A., Doring, A., Wichmann, H.E., Koenig, W. (1997). Increased plasma viscosity 
during an air pollution episode: a link to mortality? Lancet. 349, 1582-7. 
Peters, A., Pope, C.A. III. (2002). Cardiopulmonary mortality and air pollution. 
Lancet.360, 1184-1185. 
Peters, A., von Klot, S., Heier, M., Trentinaglia, I., Hormann, A., Wichmann, H.E., 
Lowel, H. (2004). Cooperative Health Research in the Region of Augsburg Study 
Group. Exposure to traffic and the onset of myocardial infarction. N Engl J Med.351, 
1721-30. 
Peterson, J. D., Herzenberg, L. A., Vasquez, K., and Waltenbaugh, C. (1998). 
Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response 
patterns. Proc. Natl. Acad. Sci. U.S.A. 95, 3071–3076. 
 
Pinkus, R., Weiner, L.M., Daniel, V. (1996). Role of oxidants and antioxidants in the 
induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. J Biol 
Chem. 271, 13422-9.  
Pohjola, S.K., Lappi, M., Honkanen, M., Rantanen, L., Savela, K. (2003). DNA binding 
of polycyclic aromatic hydrocarbons in a human bronchial epithelial cell line treated 
 112 
with diesel and gasoline particulate extracts and benzo[a]pyrene. Mutagenesis. 18, 429-
38. 
 
Rahman, I. (2005). The role of oxidative stress in the pathogenesis of COPD: 
implications for therapy. Treat Respir Med. 4, 175-200.  
 
Reger, R., Hancock, J., Hankinson, J., Hearl, F., Merchant, J. (1982). Coal miners 
exposed to diesel exhaust emissions. Ann Occup Hyg. 26, 799-815. 
 
Rengasamy, A., Barger, M.W., Kane, E., Ma, J. K. H., Castranova, V., and Ma, J. Y. C. 
(2003). Diesel exhaust particles-induced alterations of pulmonary phase I and phase II 
enzymes of rats. J. Toxicol. Environ. Health 66, 153–167. 
 
Ricci, M., Matucci, A., Rossi, O. (1994). T cells, cytokines, IgE and allergic airways 
inflammation. J Investig Allergol Clin Immunol. 4, 214-20. 
 
Ricciardolo, F. (2003). Multiple roles of nitric oxide in the airways. Thorax 58, 75–182. 
 
Ricciardolo, F. L., Timmers, M. C., Geppetti, P., van Schadewijk, A., Brahim, J. J., Sont, 
J. K., de Gouw, H. W., Hiemstra, P. S., van Krieken, J. H., and Sterk, P. J. (2001). 
Allergen-induced impairment of bronchoprotective nitric oxide synthesis in asthma. J. 
Allergy Clin. Immunol. 108, 198–204. 
 
 Robinson, D., Hamid, Q., Bentley, A., Ying, S., Kay, A.B, Durham, S.R.. (1993). 
Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and 
eosinophils recruitment in bronchoalveolar lavage after allergen inhalation challenge in 
patients with atopic asthma. J. Allergy Clin. Immunol. 92, 313–24. 
 
Robertson, A., Dodgson, J., Collings, P., Seaton, A. (1984). Exposure to oxides of 
nitrogen: respiratory symptoms and lung function in British coalminers. Br J Ind Med. 
41, 214-9. 
 
Robinson, D. S. (2000). The Th1 and Th2 concept in atopic allergic disease. Chem. 
Immunol. 78, 50-61. 
 
Robinson, D. S., Tsicopoulos, A., Meng, Q., Durham, S., Kay, A. B., and Hamid, Q. 
(1996). Increased interleukin-10 messenger RNA expression in atopic allergy and 
asthma. Am. J. Respir. Cell Mol. Biol. 14, 113-117.  
 
Sadeghi-Hashjin, G., Folkerts, G., Henricks, P.A., Verheyen, A.K., van der Linde, H.J., 
van Ark, I., Coene, A., Nijkamp, F.P. (1996). Peroxynitrite induces airway 
hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med. 
153, 1697-701. 
 
 113 
Sagai, M., Furuyama, A., and Ichinose, T. (1996). Biological effects of diesel exhaust 
particles (DEP), III: Pathogenesis of asthma-like symptoms in mice. Free Radic. Biol. 
Med. 21, 199-209. 
 
Saito, Y., Azuma, A., Kudo, S., Takizawa, H., and Sugawara, I. (2002). Effects of diesel 
exhaust on murine alveolar macrophages and a macrophage cell line. Exp. Lung Res. 
28, 201–217. 
 
Salvi, S., Blomberg, A., Rudell, B., Kelly, F., Sandstrom, T., Holgate, S.T., Frew, A. 
(1999). Acute inflammatory responses in the airways and peripheral blood after short-
term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care 
Med. 159, 702-9.   
Salvi, S.S., Nordenhall, C., Blomberg, A., Rudell, B., Pourazar, J., Kelly, F.J., Wilson, S., 
Sandstrom, T., Holgate, S.T., Frew, A.J. (2000). Acute exposure to diesel exhaust 
increases IL-8 and GRO-alpha production in healthy human Am J Respir Crit Care 
Med. 161, 550-7. 
Samet, J.M., Dominici, F., Curriero, F.C., Coursac, I., Zeger, S.L. (2000). Fine particulate 
air pollution and mortality in 20 U.S. cities, 1987-1994. N Engl J Med. 343, 1742-9. 
Sanders, S.P., Zweier, J.L., Harrison, S.J., Trush, M.A., Rembish, S.J., Liu, M.C. (1995). 
Spontaneous oxygen radical production at sites of antigen challenge in allergic subjects. 
Am J Respir Crit Care Med. 151, 1725-33. 
Saverin, R., Braunlich, A., Dahmann, D., Enderlein, G., Heuchert, G. (1999). Diesel 
exhaust and lung cancer mortality in potash mining. Am J Ind Med. 36, 415-22.  
Sato, H., Sone, H., Sagai, M., Suzuki, K.T., Aoki, Y. (2000). Increase in mutation 
frequency in lung of Big Blue rat by exposure to diesel exhaust. Carcinogenesis. 21, 
653-61. 
  
Schauer, U., Leinhaas, C., Jager, R., Rieger, C.H. (1991). Enhanced superoxide 
generation by eosinophils from asthmatic children. Int Arch Allergy Appl Immunol. 96, 
317-21. 
Scheepers, P.T., Bos, R.P. (1992). Combustion of diesel fuel from a toxicological 
perspective. I. Origin of incomplete combustion products. Int Arch Occup Environ 
Health, 64, 149–161.  
Scheepers, P.T., Coggon, D., Knudsen, L.E., Anzion, R., Autrup, H., Bogovski, S., Bos, 
R.P., Dahmann, D., Farmer, P., Martin, E.A., Micka, V., Muzyka, V., Neumann, H.G., 
Poole, J., Schmidt-Ott, A., Seiler, F., Volf, J., Zwirner-Baier, I. (2002). BIOMarkers for 
occupational diesel exhaust exposure monitoring (BIOMODEM)- a study in 
underground mining. Toxicol Lett. 1343, 305-17. 
 114 
Scheepers, P.T., Micka, V., Muzyka, V., Anzion, R., Dahmann, D., Poole, J., Bos, R.P. 
(2003). Exposure to dust and particle-associated 1-nitropyrene of drivers of diesel-
powered equipment in underground mining. Ann Occup Hyg. 47, 379-88.  
Schikowski, T., Sugiri, D., Ranft, U., Gehring, U., Heinrich, J., Wichmann, H.E., 
Kramer, U. (2005). Long-term air pollution exposure and living close to busy roads are 
associated with COPD in women. Respir Res. 6, 152. 
Schins, R.P., Borm, P.J. (1999). Mechanisms and mediators in coal dust induced toxicity: 
a review. Ann Occup Hyg. 43, 7-33.  
Schins, R.P., Schilderman, P.A., Borm, P.J. (1995). Oxidative DNA damage in peripheral 
blood lymphocytes of coal workers,. Int Arch Occup Environ Health. 67, 153-7. 
Schraufstatter, I., Hyslop, P.A., Jackson, J.H., Cochrane, C.G. (1988). Oxidant-induced 
DNA damage of target cells. J Clin Invest. 82, 1040-50. 
Schuetzle, D. (1983). Sampling of vehicle emissions for chemical analysis and biological 
testing. Environ Health Perspect. 47, 65-80.  
Schwartz, J. (1994). Air pollution and daily mortality: a review and meta analysis. 
Environ Res. 64, 36–52. 
Seaton, A., MacNee, W., Donaldson, K., Godden, D. (1995). Particulate air pollution and 
acute health effects. Lancet. 345, 176-8. 
Seaton, A., Soutar, A., Crawford, V., Elton, R., McNerlan, S., Cherrie, J., Watt, M., 
Agius, R., Stout, R. (1999). Particulate air pollution and the blood. Thorax. 54, 1027-
32. 
Sedgwick, J.B., Geiger, K.M., Busse, W.W. (1990). Superoxide generation by hypodense 
eosinophils from patients with asthma. Am Rev Respir Dis. 142, 120-5. 
Seltzer J, Bigby BG, Stulbarg M, Holtzman MJ, Nadel JA, Ueki IF, Leikauf GD, Goetzl 
EJ, Boushey HA. (1986). O3-induced change in bronchial reactivity to methacholine 
and airway inflammation in humans. J Appl Physiol., 60(4):1321-6. 
Sjögren, B. (1998a). Mortality of Dutch coal miners in relation to pneumoconiosis, 
chronic obstructive pulmonary disease, and lung function. Occup Environment Med. 
55, 503–503.  
Sjögren, B. (1998b). A possible connection between furnace dust exposure, plasma 
fibrinogen levels and cardiovascular disease. Scand J Work Environ Health. 24, 236–
237. 
Stayner, L., Dankovic, D., Smith, R., Steenland, K. (1998). Predicted lung cancer risk 
among miners exposed to diesel exhaust particles. Am J Ind Med. 34, 207-19.  
 115 
Stearns, R.C., Lawrence, J., Murthy, G.G., Diaz, E., Koutrakis, P., Suh, H., Tsuda, A., 
Godleski, J.J. (2002). Lung inflammation induced by concentrated ambient air particles 
is related to particle composition. Am J Respir Crit Care Med. 165, 1610-7.  
Steenland, K., Deddens, J., Stayner, L. (1998). Diesel exhaust and lung cancer in the 
trucking industry: exposure-response analyses and risk assessment. Am J Ind Med. 34, 
220-8. 
Steenland, N.K., Silverman, D.T., Hornung, R.W. (1990). Case-control study of lung 
cancer and truck driving in the Teamsters Union. Am J Public Health. 80, 670-4.  
Steerenberg, P. A., Dormans, J. A., van Doorn, C. C., Middendorp, S., Vos, J. G., and 
van Loveren, H. (1999). A pollen model in the rat for testing adjuvant activity of air 
pollution components. Inhal. Toxicol. 11, 1109–1122. 
 
Steerenberg, P. A., Withagen, C. E., Dormans, J. A., van Dalen, W. J., van Loveren, H., 
and Casee, F. R. (2003). Adjuvant activity of various diesel exhaust and ambient 
particles in two allergic models. Toxicol. Environ. Health A 66, 1421–1439. 
Stenfors, N., Nordenhall, C., Salvi, S.S., Mudway, I., Soderberg, M., Blomberg, A., 
Helleday, R., Levin, J.O., Holgate, S.T., Kelly, F.J., Frew, A.J., Sandstrom, T. (2004). 
Different airway inflammatory responses in asthmatic and healthy humans exposed to 
diesel. Eur Respir J. 23, 82-6. 
 
Svartengren, M., Strand, V., Bylin, G., Jarup, L., Pershagen, G. (2000). Short-term 
exposure to air pollution in a road tunnel enhances the asthmatic response to allergen. 
Eur Respir J. 15, 716-24. 
 
Sydbom, A., Blomberg, A., Parnia, S., Stenfors, N., Sandstrom, T., Dahlen, S.E. (2001). 
Health effects of diesel exhaust emissions. Eur Respir J. 17,733-46. 
 
Takano, H., Ichinose, T., Miyabara, Y., Shibuya, T., Lim, H. B., Yoshikawa, T., and 
Sagai, M. (1998). Inhalation of diesel exhaust enhances allergen-related eosinophil 
recruitment and airway hyperresponsiveness in mice. Toxicol. Appl. Pharmacol. 150, 
328–337. 
 
Takano, H.,Yoshikawa, T., Ichinose, T., Miyabara,Y., Imaoka, K., and Sagai, M. (1997). 
Diesel exhaust particles enhance antigen-induced airway inflammation and local 
cytokine expression in mice. Am. J. Respir. Crit. Care Med. 156, 36–42. 
 
Takafuji, S., Suzuki, S., Koizumi, K., Tadokoro, K., Miyamoto, T., Ikemori, R., 
Muranaka, M. (1987). Diesel-exhaust particulates inoculated by the intranasal route 
have an adjuvant activity for IgE production in mice. J Allergy Clin Immunol.  79, 639-
645. 
 116 
Takenaka, H., Zhang, K., Diaz-Sanchez, D., Tsien, A., Saxon, A. (1995). Enhanced 
human IgE production results from exposure to the aromatic hydrocarbons from diesel 
exhaust: direct effects on B-cell IgE production. J Allergy Clin Immunol. 95, 103-15.  
Takizawa, H., Abe, S., Okazaki, H., Kohyama, T., Sugawara, I., Saito, Y., Ohtoshi, T., 
Kawasaki, S., Desaki, M., Nakahara, K., Yamamoto, K., Matsushima, K., Tanaka, M., 
Sagai, M., Kudoh, S. (2003). Diesel exhaust particles upregulate eotaxin gene 
expression in human bronchial epithelial cells via nuclear factor-kappa B-dependent 
pathway. Am J Physiol Lung Cell Mol Physiol. 284, L1055-62. 
Takizawa, H., Ohtoshi, T., Kawasaki, S., Kohyama, T., Desaki, M., Kasama, T., 
Kobayashi, K., Nakahara, K., Yamamoto, K., Matsushima, K., Kudoh, S. (1999). 
Diesel exhaust particles induce NF-kappa B activation in human bronchial epithelial 
cells in vitro: importance in cytokine transcription. J Immunol. 162, 4705-11.  
Tao, F., Gonzalez-Flecha, B., Kobzik, L. (2003). Reactive oxygen species in pulmonary 
inflammation by ambient particulates. Free Radic Biol Med. 35, 327-40. 
Takano, H., Ichinose, T., Miyabara, Y., Shibuya, T., Lim, H. B., Yoshikawa, T., and  
Sagai, M. (1998). Inhalation of diesel exhaust enhances allergen-related eosinophil  
recruitment and airway hyperresponsiveness in mice. Toxicol. Appl. Pharmacol. 150,  
328–337. 
 
Takano, H., Yoshikawa, T., Ichinose, T., Miyabara, Y., Imaoka, K., Sagai, M. (1997). 
Diesel exhaust particles enhance antigen-induced airway inflammation and local 
cytokine expression in mice. Am J Respir Crit Care Med. 156, 36-42. 
Terada, N., Maesako, K., Hiruma, K., Hamano, N., Houki, G., Konno, A., Ikeda, T., Sai, 
M. (1997). Diesel exhaust particulates enhance eosinophil adhesion to nasal epithelial 
cells and cause degranulation. Int Arch Allergy Immunol. 114, 167-74.  
Teramoto, S., Shu, C.Y., Ouchi, Y., Fukuchi, Y. (1996). Increased spontaneous 
production and generation of superoxide anion by blood neutrophils in patients with 
asthma. J Asthma. 33, 149-55. 
Tokiwa, H., Sera, N., Nakanishi, Y., Sagai, M. (1999). 8-Hydroxyguanosine formed in 
human lung tissues and the association with diesel exhaust particles. Free Radic Biol 
Med. 27, 1251-8. 
Trifilieff, A., Fujitani, Y., Mentz, F., Dugas, B., Fuentes, M., Bertrand, C. (2000). 
Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice 
through down-regulation of chemokine expression. J Immunol. 165, 1526-33. 
Trush, M.A., Kensler, T.W. (1991). An overview of the relationship between oxidative 
stress and chemical carcinogenesis. Free Radic Biol Med. 10, 201-9. 
Tsien, A., Diaz-Sanchez, D., Ma, J., Saxon, A. (1997). The organic component of diesel 
exhaust particles and phenanthrene, a major polyaromatic hydrocarbon constituent, 
 117 
enhances IgE production by IgE-secreting EBV-transformed human B cells in vitro. 
Toxicol Appl Pharmacol. 142, 256-63. 
Tsurudome, Y., Hirano, T., Yamato, H., Tanaka, I., Sagai, M., Hirano, H., Nagata, N., 
Itoh, H., Kasai, H. (1999). Changes in levels of 8-hydroxyguanine in DNA, its repair 
and OGG1 mRNA in rat lungs after intratracheal administration of diesel exhaust 
particles. Carcinogenesis.  20, 1573-6. 
 
Ulvestad, B., Bakke, B., Melbostad, E., Fuglerud, P., Kongerud, J., Lund, M.B. (2000). 
Increased risk of obstructive pulmonary disease in tunnel workers. Thorax. 55, 277-82. 
U.S. Department of Labor, Mine Safety, and Health Administration. (1998). Diesel 
particulate matter exposure of underground metal and nonmetal mines, 30 CFR 57. Fed 
Reg 63, 58104-58148. 
U.S.Envionmental Protection Agency. (2002). Health assessment document for diesel 
exhaust. Washington, DC,  U.S.EPA. 
Van Zijverden, M., and Granum, B. (2000). Adjuvant activity of particulate pollutants in     
different mouse models. Toxicology 152, 69–77. 
 
Vouk, V.B., Piver, W.T. (1983). Metallic elements in fossil fuel combustion products: 
amounts and form of emissions and evaluation of carcinogenicity and mutagenicity. 
Environ Health Perspect.  47, 201-25. 
 
Wade, J.F., Newman, L.S. (1993). Diesel asthma: reactive airways disease following   
overexposure to locomotive exhaust. J Occup Med.  35, 149-154. 
 
Whitekus, M.J., Li, N., Zhang, M., Wang, M., Horwitz, M.A., Nelson, S.K., Horwitz, 
L.D., Brechun, N., Diaz-Sanchez, D., Nel, A.E. (2002). Thiol antioxidants inhibit the 
adjuvant effects of aerosolized diesel exhaust particles in a murine model for 
ovalbumin sensitization. J Immunol. 168, 2560-7. 
 
Wood, L.G., Fitzgerald, D.A., Gibson, P.G., Cooper, D.M., Garg, M.L. (2000). Lipid 
peroxidation as determined by plasma isoprostanes is related to disease severity in mild 
asthma. Lipids. 35, 967-74. 
 
Yang, H. M., Barger, M. W., Castranova, V., Ma, J. K. H., Yang, J. J., and Ma, J. Y. C.  
(1999). Effects of diesel exhaust particles (DEP), carbon black, and silica on 
macrophage responses to lipopolysaccharide: Evidence of DEP suppression of 
macrophage activity. J. Toxicol. Environ. Health 58, 261–278. 
 
Yang, X., Wang, S., Fan, Y., and Han, X. (2000). IL-10 deficiency prevents IL-5 
overproduction and eosinophilic inflammation in a murine model of asthmalike 
reaction. Eur. J. Immunol. 30, 382–391. 
 
 118 
Yin, X. J., Dong, C. C., Ma, J. Y. C., Antonini, J. M., Roberts, J. R., Stanley, C. F., 
Schafer, R., and Ma, J. K. H. (2004a). Suppression of cell-mediated immune responses 
to Listeria infection by repeated exposure to diesel exhaust particles in Brown Norway 
rats. Toxicol. Sci. 77, 263–271. 
 
Yin, X.J., Dong, C.C., Ma, J.Y., Roberts, J.R., Antonini, J.M., and Ma, J.K.H. (2006). 
Suppression of phagocytotic and bactericidal functions of rat alveolar macrophages by 
the organic components of diesel exhaust particles. J Toxicol Environ Health A, in 
press. 
 
Yin, X. J., Ma, J. Y. C., Antonini, J. M., Castranova, V., and Ma, J. K. H. (2004b). Roles 
of reactive oxygen species and heme oxygenase-1 in modulation of alveolar 
macrophage-mediated pulmonary immune responses to Listeria monocytogenes by 
diesel exhaust particles. Toxicol. Sci. 82, 143–153. 
 
Yin, X. J., Schafer, R., Ma, J. Y. C., Antonini, J. M., Weissman, D. N., Siegel, P. D., 
Barger, M. W., Roberts, J. R., and Ma, J. K. H. (2002). Alteration of pulmonary 
immunity to Listeria monocytogenes by diesel exhaust particles (DEP). I. Effects of 
DEP on early pulmonary responses. Environ. Health Perspect. 110, 1105–1111. 
 
Yin, X.J., Schafer, R., Ma, J.Y.C., Antonini, J.M., Roberts, J.R., Weissman, D.N., Siegel, 
P.D., and Ma, J.K.H. (2003). Alteration of pulmonary immunity to Listeria 
monocytogenes by diesel exhaust particles (DEP). II. Effects of DEP on T-cell-
mediated immune responses in rats. Environ Health Perspect. 111,524-30.  
 
Yoneda. K., Rokutan, K., Nakamura, Y., Yanagawa, H., Kondo-Teshima, S., Sone, S. 
(2004). Stimulation of human bronchial epithelial cells by IgE-dependent histamine-
releasing factor. Am J Physiol Lung Cell Mol Physiol. 286, L174-81. 
 
 Zandi, E., Rothwarf, D.M., Delhase, M., Hayakawa, M., Karin, M. (1997). The IkappaB 
kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary 
for IkappaB phosphorylation and NF-kappaB activation. Cell.  91, 243-52. 
 
Zanobetti, A., Schwartz, J. (2005). The effect of particulate air pollution on emergency 
admissions for myocardial infarction: a multicity case-crossover analysis. Environ 
Health Perspect. 113, 978-82. 
 
 
 
 
 
 
 
 
 
 
